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 Introduction
Menière’s disease (MD) is a triad of symptoms including episodic vertigo, 
hearing loss, and tinnitus. The idea of these three symptoms originating from 
the inner ear was ﬁ rst introduced in 1861 by Prosper Menière, but the etiology 
and pathogenesis behind the disease bearing his name are still poorly under-
stood (Beasley and Jones 1996). 
MD most often affects people in middle age. Only in a small portion of MD 
patients is the disease established as full triad from the onset. The initial symp-
toms are often cochlear and they may be attributed to another origin or simply 
to aging. After the vestibular symptoms join the cochlear symptoms, the long 
remission periods from vertigo may mask the disease’s episodic nature, and the 
entity of symptoms, and thus, the disease behind the symptoms remains unrec-
ognized (Arenberg et al. 1980; Tokumasu et al. 1996).
The diagnosis of MD has been problematic since no single test exists for 
deﬁ nitive diagnosis. Each generation of otologists develops new diagnostic tests 
for MD, but no deﬁ nite test has been found and even today many view MD as a 
diagnosis of exclusion (Levine et al. 1998). 
The lack of long-standing consensus on the diagnostic criteria of MD makes 
it difﬁ cult to compare prevalence ﬁ gures. The American Academy of Otolaryn-
gology – Head and Neck Surgery (AAO–HNS) has redeﬁ ned the criteria of MD 
twice since 1972. The most recent criteria, established in 1995, were the ones 
adopted in this study (AAO–HNS 1995). 
Previous estimations of prevalence of MD have been derived from medical 
databases. The objective of the present work was to study the prevalence of MD 
in a general population and to evaluate the presence of three major symptoms of 
MD by duration of disease.
introduction 11
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 1. 
Review of the 
Literature
 1.1 Historical Background
 1.1.1 Prosper Menière
Prosper Menière was born in Angers, western France, in 1799 — the year Napo-
leon Bonaparte came into power. After receiving his doctorate of medicine in 
1828, Menière worked as a doctor in several different positions, but later serving 
as Director of the Institute for Deaf-Mutes in Paris, which was one of the largest 
centers of medicine at that time. In the mid-19th century, the role of the inner 
ear as an organ of hearing was known since cochlear damage was seen to result 
in hearing loss, but the functions of the inner ear in maintaining balance and 
orientation had not yet been discovered. Vertigo, epileptic seizures, hysteria, and 
brain attacks were all gathered together under the puzzling idiom of “apoplec-
tiform cerebral congestion”, a state believed to be caused by congestion of the 
blood vessels of the brain. In 1861, at the age of 61 years, Menière presented his 
famous paper before the French Academy of Medicine which postulated that the 
symptoms of patients with episodic vertigo, hearing loss, and tinnitus originated 
from the labyrinth instead of the brain (Baloh 2001) . 
The most convincing proof of the inner ear being the cause of vertigo was a 
case of young girl who had suddenly become completely deaf and experienced 
constant vertigo in conjunction with an inﬂ uenzal illness. Subsequent autopsy 
ﬁ ndings revealed that her semicircular canals were ﬁ lled with bloody exudate, 
but no intracerebral disease was apparent (Menière 1861). Based on Menière’s 
experience treating many patients with combinated vertigo and hearing loss 
at the Deaf-Mute Institute, he pointed out that episodic vertigo usually had a 
benign course and the treatments typically used, including bleeding, leeching, 
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cupping, and purging, could be more harmful that the disease itself. Menière 
died of pneumonia in 1862 at the age of 62 years amidst the academic turmoil 
that his remarks had created (Beasley and Jones 1996; Baloh 2001).
 1.1.2 After Menière
In 1874, the term ‘Maladie de Menière’ was used for the ﬁ rst time by Charcot, 
who discussed the triad of vertigo, hearing loss, and tinnitus described by 
Menière. He believed that no treatment existed for the disease but pointed 
out that its progression ceased upon the occurrence of total hearing loss. The 
term ‘Menière’s disease’ was used in 1880 in the Edinburgh Medical Journal by 
McBride and James. They speculated that the cause of the disease was an organic 
lesion of the semicircular canals, an inﬂ ammation of the middle ear or increased 
pressure in the labyrinth, but one year later McBride speciﬁ ed the reason to be 
hemorrhage into the semicircular canals (Beasley and Jones 1996).
In 1902, in Vienna, Politzer deﬁ ned MD as an apoplectiform form of sudden 
deafness and vertigo arising from the labyrinth. His description of symptoms 
also included gait disturbances, diplopia, hemianopia, and short episodes of 
loss of consciousness. In 1928, Dandy recognized the symptom complex con-
sisting of vertigo, nausea, tinnitus, and progressive hearing loss and speculated 
the underlying cause to be in the vestibular nerve rather than in the semicircular 
canals since patients had both auditory and vestibular symptoms (Beasley and 
Jones 1996). In 1938, Hallpike and Cairns in London and Yamakawa in Japan 
independently described the pathological ﬁ nding of endolymphatic hydrops in 
the temporal bones of patients with MD at autopsy. 
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 1.2 Etiology
Although MD has been well characterized histopathologically by the presence 
of endolymphatic hydrops, the etiology and pathogenesis of the process remain 
unknown. Recent studies have indicated a possible role of autoimmune pro-
cesses, endocrine function, infection, allergy, and genetic factors in the eti-
ology. When the causative agent is known, it has been customary to speak about 
Menière’s syndrome, reserving the term MD for the symptom triad of unknown 
etiology (Hamid and Sismanis 2001). 
 1.2.1 Autoimmune Processes
McCabe (1979) introduced the idea that autoimmunity might damage the lab-
yrinth, showing that bilateral, progressive sensorineural hearing loss improved 
following immunosuppressive therapy, namely cortisone and cyclophospha-
mide. The autoimmune mechanism has also been presented to be etiological 
factor in MD based on a clinical response to treatment with steroids and immu-
nosuppressive medication, elevated levels of circulating immunocomplexes in 
serum (Derebery et al. 1991), and increased natural killer cell activity (Fuse et al. 
2003). 
Using Western blot assays as a test for autoimmune inner ear disorder, anti-
bodies against a 68-kilodalton protein, heat shock protein 70, as well as anti-
bodies of other molecular weights, have been found in sera of MD patients (Bill-
ings et al. 1995; Gottschlich et al. 1995; Ryan et al. 2001; Riente et al. 2004). 
Rauch et al. (1995) found anti-heat shock protein 70 antibodies in 47% of uni-
lateral and in 58% of bilateral MD patients but also observed high prevalence of 
these antibodies in control subjects. Thus, heat shock protein 70 did not prove 
useful in diagnosing MD (Rauch et al. 2000). Whether a subgroup of patients 
has immunomediated MD remains unclear (Ryan et al. 2001).
 
 
1.2.2 Endocrine Function
High plasma concentrations of antidiuretic hormone levels in MD patients with 
bilateral disease compared with a control population have been reported (Takeda 
et al. 1995; Lim et al. 2003). Exogenous administration of aldosterone results 
in endolymphatic hydrops in animals, and the secretion of this mineralocorti-
coid hormone is increased in emotional stress, a state in which MD symptoms 
often manifest. However, no differences in plasma aldosterone levels between 
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uni- and bilateral MD patients or between MD patients and normal subjects 
have been found (Mateijsen et al. 2001a). Brenner et al. (2004) reported a sig-
niﬁ cantly higher rate of thyroid hormone supplement use among MD patients 
(32%) than among controls matched for age and sex (4%). 
 1.2.3 Viruses and Allergies
Herpes simplex has more commonly been isolated from the vestibular ganglia 
of patients with MD than in the general population (100% vs. 81%), suggesting 
a viral origin of the disease (Vrabec 2003). Latent virus-speciﬁ c immunoglob-
ulin E-mediated inﬂ ammation has been considered to have a role in the initia-
tion and/or sustenance of MD (Calenoff et al. 1995). Duke (1923) was the ﬁ rst to 
suspect an allergic etiology for MD. An association between MD and food allergy 
(Clemis 1967; Endicott and Stucker 1977) and subjective improvement in symp-
toms of MD and allergy after treatment with desensitization and diet modiﬁ ca-
tion have subsequently been reported (Derebery 2000). 
 1.2.4 Genetic Factors
Strong evidence exists of a genetic predisposition to MD, with anticipation, 
familial occurrence, and an association with migraine and human leukocyte 
antigens (HLA) (Morrison and Johnson 2002; Oliveira et al. 2002). Morrison 
found 41 parent-child pairs with a mean 17.5-year difference in age at onset, to 
possess “anticipation”, which means that in addition to earlier onset of the dis-
ease in successive generations there is also a tendency towards more severe 
manifestation. The mode of inheritance has been presented as autosomal dom-
inant, with 60% penetrance of the mutation. The familial frequency of MD has 
been estimated to be 7% (Morrison 1995; Morrison and Johnson 2002). 
The COCH (coagulation factor C homolog, cochlin) gene in chromosome 
14 is the only gene identiﬁ ed to cause autosomal dominantly inherited hearing 
loss associated with vestibular dysfunction in humans. Six different mutations 
have been reported worldwide, and in some of these, the penetrance of vestib-
ular symptoms is complete, resembling the clinical picture of MD (Usami et al. 
2003). Fransen et al. (1999) were the ﬁ rst to report a mutation of a COCH gene 
leading to symptoms of MD in a signiﬁ cant portion of carriers; more than 25% 
of patients affected expressed episodic vertigo, tinnitus, hearing loss, and aural 
fullness. Based on this ﬁ nding, they stated that COCH mutation should be con-
sidered in MD patients. 
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Usami et al. (2003) came to the conclusion that mutations in the COCH gene 
were a frequent cause of autosomal dominant progressive cochleovestibular dys-
function, but not of sporadic MD. This conclusion was based on their study con-
ducted in Japan, in which they detected no mutations in sporadic MD patients. 
In addition they found a new mutation, the ﬁ ve previous mutations all being 
found in families of European ancestry. 
 1.2.5 Other Causes
Otitis media, otosclerosis, acoustic trauma, and developmental factors, such as 
hypoplasia and narrowing of the vestibular aquaduct, impaired pneumatization 
of the temporal bone, perisaccular ﬁ brosis, and atrophy or hypoplasia of the sac, 
have been suggested as etiologic factors in MD (Mancini et al. 2002; Paparella 
and Djalilian 2002).
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 1.3 Epidemiology
 1.3.1 Prevalence Estimations
 Prevalence in Europe
In an early epidemiological study, Cawthorne and Hewlett (1954) reported the 
occurrence of MD to be 157 per 100 000 individuals in Great Britain. Harrison 
and Naftalin (1968), by contrast, described the English incidence to be 100/
100 000. In Sweden, Stahle et al. (1978) found an incidence of 46/100 000 in 
their study of inpatients and outpatients possessing the complete triad of MD 
symptoms. Wilmot (1979) reported an incidence of 10-20/100 000 in Northern 
Ireland based on his own clinical records. In Italy, the prevalence has been 
observed to be 8/100 000, with this ﬁ gure estimated to be 3.4 times higher 
among hospital personnel (Celestino and Ralli 1991).
 Kotimäki et al. (1999) assessed the prevalence of MD in Finland by re-evalu-
ating the hospital records of 306 MD patients treated in 7 different hospitals in 
Finland. Using the AAO-HNS 1995 criteria, they reported the prevalence of MD 
to be 43/100 000, but concluded that the prevalence is probably underestimated 
when using a retrospective method. They chose an investigation period of 5 
years to also include those patients not visiting the hospital every year. However, 
they reported the possibility of some deﬁ nite MD patients still being missed due 
the long remission periods in the disease.
 Prevalence outside Europe
In the United States, a prevalence of 218/100 000 has been reported (Wladisla-
vosky-Waserman et al. 1984). Their criteria included cases with vestibular, 
cochlear, and classic MD, and the classic form was deﬁ ned as having both 
cochlear and vestibular symptoms with or without tinnitus. Watanabe et al. 
(1995) described a prevalence of 16-17/100 000 in Japan in a study that was not 
population-based. A relative frequency of 400/100 000 was found in a Nige-
rian black community (Okafor 1984). MD is apparently very rare among native 
Americans, i.e. southwestern American Indians (Wiet 1979). Some of the pre-
vious occurrence estimations of MD and criteria used in patient selection are 
presented in Table 1.
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Table 1. 
Evaluations of the occurrence of Menière’s disease.
 Occurrence
Investigator (year)  / 100 000  Country  Source of data Criteria
Cawthorne and Hewlett (1954) 157 Great Britain Medical records Undeﬁ ned
Harrison and Naftalin (1968) 100 Great Britain Undeﬁ ned Undeﬁ ned
Stahle et al. (1978) 46 Sweden Medical records Complete triad
Wilmot (1979) 10-20 Northern  Clinical records Undeﬁ ned
  Ireland
Okafor (1984)  400 Nigeria Medical records Rotatory vertigo of an   
    episodic nature, 
    ﬂ uctuating cochlear 
    symptoms. Negative 
    ﬁ ndings in other diseases.
Wladislavosky-Waserman  218 United States Medical database Vestibular, cochlear or   
et al. (1984)    classic MD with or without  
    tinnitus.
Celestino and Ralli (1991) 8 Italy Medical records AAO-HNS 1972
Watanabe et al. (1995) 16-17 Japan Medical records Repeated attacks of vertigo,  
    ﬂ uctuating cochlear 
    symptoms with vertigo,   
    exclusion of central 
    nervous system diseases.
Kotimäki et al. (1999) 43 Finland Medical records AAO-HNS 1995
 1.3.2 Age and Gender Distribution
The mean age of patients at onset of disease is 38-50 years (Stahle et al. 1991; 
Lee et al. 1995; Katsarkas 1996; Tokumasu et al. 1996). Ballester et al. (2002) 
reported MD to be common in elderly people based on a prevalence rate of 5% 
among balance-disordered people aged over 65 years. MD has been diagnosed in 
patients up to 90 years of age. As life span lengthens, the prevalence of MD in 
the oldest age groups is forecasted to increase (Mancini et al. 2002). Wladisla-
vosky-Waserman et al. (1994) noted a peak in incidence in the age group 45-
59 years, but estimated the rate to increase by age, with a small decrease occur-
ring in the oldest age group of more than 75 years. About 3% of all MD patients 
are reported to belong to the pediatric age group (Meyerhoff et al. 1978). Akagi 
et al. (2001) found the incidence in pediatric patients with vertigo to be 2.9%. 
Most often (30.9%), however vertigo in children without otitis media is caused 
by migraine (Choung et al. 2003). While the disease is often reported to affect 
both genders equally (Oosterveld 1979; Tokumasu et al. 1995; Katsarkas 1996), 
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some authors have found a slight female predominance (Stahle et al. 1991; Lee 
et al. 1995). 
 
 1.3.3 Bilaterality
No difference is present in the involvement of the right and left ears in MD (Lee 
et al. 1995), but the prevalence of bilateral disease has been reported to increase 
with duration of illness (Green et al. 1991; Stahle et al. 1991). Forty-seven percent 
of patients have bilateral disease after 20 years of follow-up (Friberg et al. 1984). 
The time interval for symptoms to start in the second ear can vary from zero to 
more than 20 years (Haye and Quist-Hanssen 1976). Age at onset is not corre-
lated with bilaterality of MD (Lee et al. 1995). Electrocochleography (ECoG) has 
revealed endolymphatic hydrops in the contralateral asymptomatic ear in 10% of 
MD patients regarded as having unilateral disease (Conlon and Gibson 1999).
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 1.4 Diagnostics of Menière’s Disease
The cornerstone in the diagnosis of MD is the history given by the patient, with 
the audiologic evaluation being of secondary importance. It is, however, com-
monly accepted that after patient’s history the audiologic data provide most rele-
vant information for the diagnosis of MD (Lee et al. 1995; Mancini et al. 2002). 
Advances in technology have resulted in a series of otoneurologic tests that 
increase clinicians’ ability to evaluate vestibular function in patients with balance 
disorders. There is, however, no spesiﬁ c clinical test for MD (Baloh 1998), and in 
diagnostics, the otoneurologic tests have a tertiary position. Diagnostic imaging 
studies are used principally to rule out other diseases (Mancini et al. 2002). 
In the symptom history given by the patient, it is important to distinguish 
vertigo from other types of dizziness. The physical examination should include 
complete otorhinolaryngologic and neurologic evaluation, the latter in particu-
larly, if the main complaint is balance disorder (Kumar and Petchenik 1990; 
Baloh 1995).
 The variability in MD presentation, with its remissions and exacerbations, 
can sometimes make the disease difﬁ cult to recognize. This has prompted the 
development of guidelines to increase accuracy in reporting and diagnostics 
(Devaiah and Ator 2000). 
 
 1.4.1 Diagnostic Criteria of Menière’s Disease
AAO-HNS published guidelines for the diagnosis in MD in 1972 (Alford 1972). 
These criteria were revised in 1985, when the Committee excluded the variants 
“cochlear” and “vestibular” MD based on an absence of documentation that 
these variants were related to the same pathologic disorder as MD (Pearson and 
Brackmann 1985). The criteria were revised a second time in 1995, diagnosis 
now requiring both cochlear and vestibular symptoms. These criteria still in use 
today are presented in Table 2 (AAO-HNS 1995).
Hearing loss in MD is easily documented but hard to deﬁ ne precisely. The 
AAO-HNS criteria offer few options in the diagnostics of hearing loss. The most 
useful for unilateral cases being criteria, where hearing loss is deﬁ ned as the 
average of threshold values at 0.5, 1, 2, and 3 kHz being ≥ 20 dB poorer in the 
ear in question than on the opposite side. Diagnosis in bilateral cases, involves 
the average of threshold values at 0.5, 1, 2, and 3 kHz being > 25 dB poorer in 
the studied ear. 
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Table 2. 
Criteria for diagnosis of MD (AAO-HNS 1995).
Certain MD •  Deﬁ nite MD, plus histopathologic conﬁ rmation
Deﬁ nite MD •  Two or more deﬁ nitive spontaneous episodes of vertigo lasting 20 minutes or longer
 •  Audiometrically documented hearing loss on at least one occasion
 •  Tinnitus or aural fullness in the treated ear
 •  Other causes excluded
Probable MD •  One deﬁ nitive episode of vertigo
 •  Audiometrically documented hearing loss on at least one occasion
 •  Tinnitus or aural fullness in the treated ear
 •  Other causes excluded
Possible MD •  Episodic vertigo of the Menière type without documented hearing loss, or
 •  Sensorineural hearing loss, ﬂ uctuating of ﬁ xed, with dysequilibrium but 
  without deﬁ nitive episodes
 •  Other causes excluded
 Hearing stages
Because hearing is the most readily measured variable, a staging system based 
solely on hearing has been devised by the Committee on Hearing and Equilib-
rium of AAO-HNS (Table 3). This staging is based on the four-tone average of 
the pure-tone thresholds at 0.5, 1, 2, and 3 kHz of the worst audiogram. Staging 
should, however, be applied only in cases of deﬁ nite or certain MD (AAO-HNS 
1995).
Table 3. 
Hearing stages by AAO-HNS 1995 criteria.
Stage Four-tone average of hearing thresholds at 0.5, 1, 2, and 3 kHz
1 < 26 dB
2 26–40 dB
3 41–70 dB
4 > 70 dB
 
 1.4.2 Audiologic Tests
 Audiometry
Sensorineural hearing loss has to be documented audiometrically on at least one 
occasion to justify the diagnosis of MD. The determination of hearing change 
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should be based on the four-tone average of hearing thresholds at 0.5, 1, 2, and 
3 kHz. A change of 10 dB or more is considered clinically signiﬁ cant in deter-
mination of hearing change. The four-tone average of 0.5, 1, 2, and 3 kHz has 
been chosen by AAO-HNS because it takes into account the importance of high 
frequencies in normal hearing (AAO-HNS 1995). Loudness recruitment and 
reduced speech discrimination are frequently noted in MD patients (de Sousa 
2002). In case of bilateral hearing loss with a pure-tone average (PTA) worse 
than 70 dB or word recognition worse than 50%, the diagnosis of MD should be 
questioned (AAO-HNS 1995) . 
 Electrocochleography
ECoG is a method used for measuring stimulus-related electrical potentials gen-
erated in the cochlea and auditory nerve (Odabasi et al. 2000). The three most 
important electrical phenomena in ECoG evaluation are cochlear microphonics, 
summating potential (SP), and action potential (AP). An elevated SP/AP ratio has 
been reported to be important in diagnosing MD (Gibson et al. 1983; Eaton et 
al. 2003). SP enlargement has been described as the physiological manifestation 
of endolymphatic hydrops and sensitive in diagnosing MD (Gibson and Prasher 
1983; Conlon and Gibson 2000). However, Levine et al. (1998) found ECoG to 
have limited value in diagnosing MD but they noted a correlation between dura-
tion of MD and audiometric ﬁ ndings. Pappas et al. (2000) in turn noticed no 
relationship between disease duration and ECoG results but found a signiﬁ cant 
relationship between hearing loss and elevated SP/AP ratio. 
Transtympanic promontory placement of the electrode has been reported to 
produce the best recording conditions. However, the invasive procedure needed 
in the transtympanic approach limits its clinical usefulness. The results of extra-
tympanic ECoG have been found to correlate well with the transtympanic mea-
surements. Mori et al. (1987) found extratympanic ECoG useful in diagnosing 
MD patients and an increased SP/AP amplitude ratio to be much more common 
among MD patients than among those with hearing loss of other origin. How-
ever, pathological SP/AP ratios are also observed in such diseases as sudden 
deafness and Lyme disease (Selmani et al. 2002). This decreases the speciﬁ city 
of the pathologic ﬁ nding. Recently, the SP/AP area curve ratio was reported to 
be more sensitive than the conventional SP/AP amplitude ratio in detecting MD 
patients, and a combination of ECoG and glycerol tests was effective in identi-
fying patients with atypical MD whose disease would ultimately progress to deﬁ -
nite MD (Devaiah et al. 2003; Kimura et al. 2003).
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 Auditory brainstem response
In auditory brainstem response, an auditory stimulus, usually a click, is given to 
the tested ear, after which an electric response is recorded. The ascending audi-
tory pathways connect with the central nervous system nuclei, creating a com-
plex system of auditory pathways. Auditory brainstem response is used in differ-
ential diagnostics of MD to rule out retrocochlear reasons for vertigo and hearing 
loss such as vestibular schwannomas and vascular anomalies (de Sousa et al. 
2002).
 1.4.3 Otoneurologic Tests 
 Posturography
Postural sway has been used as an indicator of balance function (Monsell et al. 
1997). Postural sway too small to be observed in everyday life can be recorded by 
force platform posturography (Terekhov 1976), which measures forces needed to 
maintain balance and support body weight (Aalto et al. 1988). The two types of 
clinical posturography used are static and dynamic posturography (Black 1982). 
Static platform posturography measures body sway while the subject stands still 
on a stationary platform, whereas dynamic platform posturography also mea-
sures the subject’s ability to stand in situations where balance is disturbed by a 
sway-referenced platform and/or visual surroundings (O’Neill et al. 1998; Evans 
and Krebs 1999). The sensitivity of static posturography has been reported to be 
57%, as opposed to 38% for dynamic posturography, in diagnosing all patients 
with peripheral vestibular deﬁ cit. However, sensitivity of posturography increases 
to 66% with regards to MD patients alone (Di Fabio 1996). Asai et al. (1993) in 
turn found dynamic posturography to be better than other postural tests in the 
detection of pathology in patients with vestibular deﬁ cient. MD patients were 
relatively unstable or fell in dynamic posturography when they were dependent 
on a vestibular system only (platform sway-referenced and vision absent or dis-
torted) (Black 1982). Evans and Krebs (1999) stated that posturography would 
only modestly enhance the diagnosis of vestibular deﬁ cit and that it could be 
utilized best in evaluating the effect of rehabilitation, and thus, assessing the 
functional status of balance-impaired subjects. Persons over 75 years have been 
reported to sway signiﬁ cantly more than younger people (Baloh et al. 1998). Pos-
tural sway is found to be most stable between the ages of 30 and 60 years, with 
sway velocity (SV) thereafter increasing due to degenerative changes in the body 
(Hytönen et al. 1993).
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 Electronystagmography
Electronystagmography (ENG) is a electrical method consisting of a set of vestib-
ular tests for monitoring eye movements using the direct current potential natu-
rally existing between the cornea and the retina. ENG can provide site-of-lesion 
information in case of vestibular deﬁ cit. With regards to MD, the most impor-
tant component of ENG is caloric test. The most frequent abnormality noticed 
in caloric testing is unilateral weakness (Bhansali and Honrubia 1999). Most 
tests on vestibular function only provide information about the asymmetry of 
the vestibular lesion affecting the horizontal semicircular canals and they reveal 
nothing about patient’s functional status since the tests are carried out in passive 
position. Abnormal caloric test results also tend to remain abnormal if the symp-
toms resolve (Asai et al. 1993).
In unilateral MD, caloric weakness has been demonstrated in 58% of patients 
on the involved side and in 19% on the normal side. Complete paralysis has been 
found in 7% of MD patients. With duration of MD, caloric responses have been 
reported to become weaker in 26% and stronger in 11% of patients. Twenty-six 
percent of the MD patients have had both increased and decreased values in 
their caloric tests when tested more than twice (Proctor 2000). Fifty-four percent 
of deﬁ nite MD patients have had abnormal tests results in ENG with caloric irri-
gation (Kotimäki 2003).
 Saccades are the fastest possible eye movements, reaching peak velocities of 
up to 700  per second. They are used to capture visual targets in the periphery 
of the visual ﬁ eld onto the fovea. Normal voluntary saccadic eye movements are 
very exact and overshooting rarely happens. Disorders of the saccadic system are 
categorized into three groups: velocity, accuracy, and latency. Abnormally slow 
saccades appear in many degenerative and metabolic diseases of the central ner-
vous system (Bhansali and Honrubia 1999). Inaccurancy has been reported in 
association with cerebellar (Baloh et al. 1977) as well as with cerebellobrainstem 
(Dahlen et al. 1980) and frontal lobe lesions (Wennmo et al. 1983). Latency dis-
orders occur in people with abnormal vision, Parkinson’s disease, or Alzheim-
er’s disease (Bhansali and Honrubia 1999). 
Pursuit eye movements are smooth traching movements of the eyes that 
match the speed of the target and make it possible to analyze the moving target 
(Bhansali and Honrubia 1999; Haarmeier and Thier 1999). In case of an 
impaired smooth pursuit system corrective saccades are needed in order to keep 
up with the target. Abnormal smooth pursuit eye movements are seen in disor-
ders throughout the central nervous system (Bhansali and Honrubia 1999). 
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 Vestibular evoked myogenic potentials
The vestibular evoked myogenic potential test is a new method used to assess 
the inner ear (Magliulo et al. 2004). Loud clicks, short tone burst, head taps, and 
short duration of transmastoid currents have been shown to activate vestibular 
receptors and evoke reﬂ ex changes in tonic electromyogram activity within the 
sternocleidomastoid muscles that can be recorded by a electromyogram (Cole-
batch 2001). The vestibular evoked myogenic potential test has been reported 
to be beneﬁ cial in identifying endolymphatic hydrops of the inner ear and, 
when combined with the glycerol test, it can diagnose early-stage endolymphatic 
hydrops (Magliulo et al. 2004). Young et al. (2003) found vestibular evoked myo-
genic potentials to correlate with the stage of MD.
 1.4.4 Imaging Studies
More detailed imaging of the inner ear and auditory pathways has been made 
possible by advancements in magnetic resonance imaging (MRI) and computer-
ized tomography (CT) (Casselman 2002). MRI rules out vestibular schwannomas 
(Rosenberg 2000; Somers et al. 2001). Congenital inner ear malformations 
can often be seen on CT, but submillimetric MRI images are essential in diag-
nosing the defects between scalae inside the cochlea as well as possible asym-
metry between scalae seen in endolymphatic hydrops (Davidson et al. 1999; Cas-
selman et al. 2001). In animal studies, high-resolution MRI can visualize and 
quantify the extent of endolymphatic hydrops (Zou et al. 2003). Silver et al. (2002) 
reported that in using a 9.4 Tesla magnetic resonance scanner, the most pow-
erful magnetic resonance magnet currently available, the most speciﬁ c structures, 
including Reissner’s membrane, can be analyzed in detail; the experience received 
via cadaver tests will eventually be extended to examining MD patients. In differ-
entiating between MD and vascular-origin syndromal vertigo, the use of MRI and 
MRA (magnetic resonance angiography) is recommended (Welsh et al. 1996).
 1.4.5 Laboratory Tests
Although laboratory tests are seldom positive in MD, they are cost-effective and 
yield information on the general health of the patient. The laboratory test panel 
should include a hemogram and determinations of erythrocyte sedimentation 
rate, C-reactive protein, thyroid function, and cholesterol, triglyceride, and glu-
cose levels. A ﬂ uorescent treponemal antibody absorption test is used to rule out 
otosyphilis (de Sousa 2002).
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 1.4.6 Differential Diagnostics
 Migraine
Migraine is a cause of recurrent vestibular symptoms, and in differential diag-
nosis, it should be taken into consideration. Migrainous vertigo includes epi-
sodic vestibular symptoms lasting from minutes to several days, an individual 
or family history of migraine, migrainous symptoms during the attack with or 
without headache, and migraine aura (Johnson 1998; Neuhauser et al. 2001). 
Vertigo and sensorineural hearing loss have been stated to occur in migraine in 
12% (Johnson 1998) to 38% (Olsson 1991) of cases. Differentiation between MD 
and migraine is complicated because the prevalence of migraine in MD patients 
is 56% vs. 25% in patients without MD, and in less than half of patients a ﬁ xed 
association exists between headache and vertigo. The prevalence of migraine is 
increased in both men and women with MD. Forty-ﬁ ve percent of MD patients 
have vertigo attacks that are invariably accompanied by at least one migrainous 
symptom, such as migrainous headache, phonophobia, or aural symptoms (Neu-
hauser et al. 2001; Radtke et al. 2002). 
The association between MD and migraine was already suggested by Prosper 
Menière in 1861. The high prevalence of migraine in MD patients and of ves-
tibulo-cochlear symptoms in migrainous vertigo raises the possibility of some 
common etiology (Neuhauser et al. 2001; Radtke et al. 2002), but no generally 
accepted mechanism to explain the connection has been presented (Baloh 1997, 
1998). Migraine has been demonstrated to damage the inner ear, causing per-
manent hearing loss and impairment of vestibular function (Lee 2000). Endo-
lymphatic hydrops presented to be the cause of MD attack (Hallpike and Cairns 
1938) has also been suggested to develop in a ear previously compromised by a 
vasospasm in the cochlear or vestibular branch of the internal auditory artery 
due to a migrainous mechanism (Baloh 1997; Lee et al. 2000, 2003). The efﬁ -
cacy of antimigrainous therapy in migraine-related dizziness has been shown to 
directly correlate with the therapy’s ability to alleviate headache, and this correla-
tion was maintained regardless of the temporal relation between headache and 
vertigo (Bikhazi et al. 1997).
 Central nervous system causes
Vertigo associated with other neurologic symptoms, such as facial weakness 
and gait ataxia, is generally attributed to vertebrobasilar ischemia, but when pre-
sented as an isolated phenomenon vertigo is frequently of more benign origin, 
often linked to peripheral vestibular disorders (Troost 1980; Grad and Baloh 
1989). Isolated vertigo has, however, also been reported to be the only symptom 
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of vertebrobasilar ischemia (Gomez et al. 1996). Vertigo and cochlear symptoms 
can result from ischemia in different branches of the vertbrobasilar territory, 
such as the posteroinferior (PICA) and anteroinferior cerebellar arteries (AICA), 
the posterior cerebral artery, and the basilar artery (Welsh et al. 1996). Adams 
(1943) was the ﬁ rst to describe association between acute ischemic stroke in the 
AICA distribution and vertigo, hearing loss, and tinnitus. Lee et al. (2002) found 
vertigo to be the initial symptom in all 12 patients with AICA in their prospective 
study. The patients had concomitant nausea and/or vomiting, and in the clinical 
examination, they all had spontaneous (horizontal-rotatory) nystagmus beating 
toward the healthy side (i.e. directed away from the side of infarction). Four 
patients (25%) had vertigo and/or auditory symptoms as an isolated manifesta-
tion from days to 2 months before infarctation. These transient symptoms lasted 
minutes, which is the typical duration of transient ischemia within the anterior 
or posterior circulation. 
Grad and Baloh (1989) have also emphasized that brief episodes (minutes) 
of audiovestibular symptoms can be a warning of upcoming brainstem stroke. 
Sudden deafness and tinnitus can result from cochlear ischemia (Matsushita et 
al. 1993; Lee et al. 2002). A cochlear site for hearing loss with AICA infarction is 
understandable because the labyrinthine artery is an end-artery without collateral 
circulation (Grad and Baloh 1989). AICA infarction is most commonly caused 
by formation of an atheroma or thrombus in the parent basilar artery which 
blocks the oriﬁ ce of AICA (Caplan 1989). Hinojosa and Kohut (1990) reported a 
loss of sensory epithelium of the cochlea and vestibular labyrinth consistent with 
inner ear infarction based on their histopathologic study of temporal bone of a 
patient with complete AICA infarction. MRA has been demonstrated to be supe-
rior in differentiating between central perfusion and vestibular disorders (Welsh 
et al. 2000).
Fluctuating hearing loss associated with vertigo and tinnitus can also be the 
initial symptom of multiple sclerosis. Other central nervous system causes that 
have to be taken into account in differential diagnostics are epilepsy, vascular 
loop compression syndrome, Arnold-Chiari malformation, arachnoid cysts, and 
tumors of the cerebellum and brainstem (Harrison and Naftalin 1968, Weber 
and Adkins 1997, Buongiorno and Ricca 2003). 
 Vestibular schwannoma
Hearing loss and tinnitus are the main symptoms of vestibular schwannoma, 
also known as acoustic neurinoma. Since vestibular schwannomas grow slowly 
or their growth is arrested, they often go undiagnosed for years. Advancements 
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in imaging studies have enabled vestibular schwannomas that would never have 
become clinically signiﬁ cant to be detected (Rosenberg 2000). Only half of the 
patients with vestibular schwannoma have vertigo (Kentala and Pyykkö 2001). 
However, 38% of patients have the full triad of vertigo, hearing loss, and tin-
nitus, and when vertigo is present it has been reported to mimic the vertigo seen 
in MD in 14% of patients. The mean duration of vertigo attacks range from 5 
minutes to 4 hours, and they most commonly occur in acute phase once or twice 
a day. Caloric asymmetry > 25% has been detected in 61% of patients (Kentala 
and Pyykkö 2000). The majority of patients aged over 65 years with vestibular 
schwannomas do not need surgery, with MRI considered to be reliable in fol-
lowing their tumor growth (Rosenberg 2000).
 Traumatic vertigo
Traumatic endolymphatic hydrops is a clinical entity caused by a history of 
head trauma. The clinical picture is characterized by episodic vertigo, ﬂ uctu-
ating hearing loss, tinnitus, and aural fullness (Shea et al. 1995). Fluctuations in 
hearing after head trauma typically occur during the ﬁ rst year, after which the 
hearing loss stabilizes (Segal et al. 2002). Pulec (1972) reported head trauma to 
be the cause of endolymphatic hydrops in 3% of patients. Temporal bone frac-
tures are capable of interrupting the endolymphatic duct in humans, leading to 
Menière’s syndrome, which includes symptoms typical of MD. Trauma-induced 
hydrops without temporal bone fractures has also been reported (Ylikoski et al. 
1982; Paparella and Mancini 1983). Obstructive hydrops can result not only from 
disruption of the endolymphatic duct because of fractures, but also from a block 
in ﬂ ow caused by blood and debris (Fitzgerald 1996).
The symptoms, which are predominantly vestibular rather than auditory, 
often start several years after the trauma (Ylikoski et al. 1982). As time increases 
between the trauma and the MD-like symptoms, the causative relationship can 
be difﬁ cult to recognize. Reduced vestibular response in ENG has been found 
to be more common in trauma-induced Menière’s syndrome than in MD, but 
auditory tests are often normal in traumatic Menière’s syndrome. MD does not 
appear to be causally related to previous acoustic trauma (Fitzgerald 1996; Segal 
et al. 2003)
 Labyrinthine ﬁ stula
Labyrinthine ﬁ stulae are anomalous communication routes between the inner 
ear and surrounding structures, leading to clinical symptoms of vertigo, hearing 
loss, and tinnitus resembeling MD. In addition, however, patients often feel per-
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sistent disequilibrium and motion intolerance, with their symptoms being exac-
erbated by visually unstable surroundings (Fitzgerald 1996; Minor 2003). Lab-
yrinthine ﬁ stula is an entity consisting of perilymphatic ﬁ stula and superior 
semicircular canal dehiscence syndrome. Perilymphatic ﬁ stula can be due to an 
excessive pressure change, trauma, erosion caused by chronic infection, or com-
plications after an ear operation (Minor 2003; Baloh 2004). In 1998, Minor et 
al. presented superior semicircular canal dehiscence syndrome, which is caused 
by bony dehiscence of the affected canal. Loud sounds (Tullio phenomenon) 
and pressure changes (Hennebert sign) were noted to result in nystagmus in 
the plane of the superior semicircular canal. Patients with this syndrome have 
sound- and pressure-induced vertigo attacks, and a positive ﬁ nding in ﬁ stula 
testing. Their air conduction thresholds are normal, but they may have an air 
bone gap - a ﬁ nding in audiogram which distinguishes them from MD patients 
(Baloh 2004). Diagnosis of the syndrome is conﬁ rmed by high-resolution CT 
scans (Minor et al. 1998).
 Benign paroxysmal positional vertigo
Benign paroxysmal positional vertigo (BPPV) is reported to be the most common 
peripheral vestibular deﬁ cit (Nedzelski et al. 1986). BPPV is characterized by a 
nystagmus that starts after a short latency, has limited duration, and is fatigued 
in repeated testing. Nystagmus results from free-ﬂ oating otoliths in the endo-
lymph of the posterior semicircular canal (Parnes and McClure 1992). Canalith 
reposition maneuvers have been reported to give good treatment results (Epley 
1992), but many people recover from their symptoms after days or months with 
no intervention (Perez et al. 2002).
Patients with BPPV have a 2–5% increased prevalence of MD, and the MD 
symptoms typically start 2–5 years before the onset of BPPV (Baloh et al. 1987; 
Gross et al. 2000). The prevalence of migraine in BPPV patients is also higher 
than in the normal population (Ishiyama et al. 2000; Lempert et al. 2000). The 
prevalence of BPPV in MD patients has been reported to be 10% (Perez et al. 
2002). BPPV can establish in the same or opposite ear as MD, or it can be bilat-
eral, but when these two vestibular deﬁ cits are present simultaneously the resul-
tant disability is higher than with BPPV alone (Dornhoffer and Colvin 2000). 
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 1.5 Clinical Course in Menière’s Disease
MD is diagnosed when the classic triad of symptoms is established. At the time 
of diagnosis, patients have often had audiologic or vestibular symptoms alone 
for months or even years (Mancini et al. 2002). The initial symptom in MD has 
been reported to be cochlear in 61%, vestibular in 18%, and a combination of the 
two in 21% of patients (Tokumasu et al. 1996).
 1.5.1 Hearing Loss
MD is characterized by progressive, sensorineural hearing loss, usually accom-
panied by a history of hearing ﬂ uctuation, loudness intolerance, diplacusis, and 
aural pressure (Lee et al. 1995). Hearing often ﬂ uctuates early in MD, but ﬂ uc-
tuation is not always present (AAO-HNS 1995). Hearing loss is considered to be 
low-frequency dominated (Antoni-Candela 1976), but the most common audio-
metric pattern can also be ﬂ at (Meurman and Grahne 1956; Enander and Stahle 
1967). The duration of MD can inﬂ uence the audiometric pattern. The pattern 
can be up-sloping (27%) or ﬂ at (55%) early in the disease but become down-
sloping as the disease progresses (Antoni-Candela 1976). Lee et al (1995) reported 
the predominant audiogram to be a peak type (50%), followed by a falling type 
(26%) and a dip type (9%). After 15 years of observation, 74% of patients were 
reported to have a ﬂ at audiogram (Friberg et al. 1984). Recently, the audiogram 
has been found to most frequently be up-sloping or peak type, with the shape of 
audiogram being independent of duration of MD (Mateijsen et al. 2001b). 
 Enander and Stahle (1967) observed the main loss of hearing to occur during 
the early years of the disease, after which the hearing level appears to stabilize, 
with the median for pure-tone audiogram, speech reception, and speech discrim-
ination scores being 56 dB, 60 dB, and 54%, respectively (Stahle 1976). After 21 
years of follow-up, Friberg et al. (1984) found no patients with a mean hearing 
loss of < 30 dB. Early in MD, hearing becomes impaired linearly with disease 
duration, but after the age of 50 years, both aging and duration of the disease 
apparently affect the hearing level (Kotimäki et al. 2001).
Profound hearing loss occurs in 1-6% of severely affected MD patients (Stahle 
1976; Shojaku et al. 1995). Patients with bilateral profound sensorineural hearing 
loss have been found to beneﬁ t from cochlear implantation (Lustig et al. 2003). 
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 1.5.2 Tinnitus
Hägnebo et al. (1997) reported tinnitus to cause the most discomfort to the 
MD patients. Tinnitus in MD can shift from a low pitched to a higher pitch 
but often is of low-frequency type, and thus, is difﬁ cult to mask with environ-
mental sounds (Vernon et al. 1980; Kolbe et al. 2000). Patients describe it as a 
roaring, buzzing, ringing, or popping sound (Stouffer and Tyler 1990). Tinnitus 
may increase during or preceding a vertigo attack and continue so for some time 
after the attack (Alford 1972). Tinnitus in MD is often severe, and its intensity is 
reported to increase with duration of the disease (Kolbe et al. 2000). During the 
course of MD tinnitus has been reported to be easier to mask by a low level of 
external sounds, and in some patients it is also believed to disappear eventually 
(Vernon et al. 1980). 
MD patients with tinnitus regard their tinnitus as more disturbing than 
patients with tinnitus due other causes, such as vestibular schwannoma, sudden 
deafness, noise-induced hearing loss, or presbyacusis (Stouffer and Tyler 1990; 
Kentala 1996). Surgery does not eliminate tinnitus, but gentamicin treatment 
offers some relief (Kaasinen et al. 1995; Feenstra 1997).
 1.5.3 Vertigo
The vertigo in MD tends to be rotational, occurring in well-deﬁ ned episodes. The 
attacks are often accompanied by nausea and sometimes vomiting and persist 
from 20 minutes to 24 hours (Alford 1972; AAO-HNS 1995). The vertigo attack 
in MD typically reaches a peak within a few minutes, remains severe for an hour 
or two, and then slowly resolves over the next few hours (Baloh 1995). Many 
people with MD experience and are adapted to low levels of vertigo and disequi-
librium between vertigo attacks (Cohen et al. 1995), but the actual attacks have 
been reported to be most problematic of the three main symptoms of MD (Mey-
erhoff et al. 1981). The ﬁ rst vertigo attack has been regarded as the onset of the 
disease by some authors (Haye and Quist-Hanssen 1976). 
Early in MD, vestibular symptoms dominate. During the active periods 1/3 of 
patients were reported to have more than 30 vertigo attacks per year (Haye and 
Quist-Hanssen 1976). After the ﬁ rst year of the disease, nausea-associated ver-
tigo attacks become less frequent (Oosterveld 1979). In a study consisting of 514 
MD patients, vertigo attacks lasted less than 10 minutes in 20%, 10–59 minutes 
in 36%, 1–4 hours in 36%, and more than 4 hours in 28%. In most cases (65%), 
the attacks occurred irregularly, in 23% during the daytime, in 7% in the eve-
nings, and in 5% during the night-time. Sixty-ﬁ ve percent of patients had to dis-
03_Havia_M   32 23.8.2004, 08:23:03
review of the literature 33
continue their activities during the attacks (Hägnebo et al. 1997). 
Vertigo attacks disappear or at least diminish over time (Stahle 1976; Fri-
berg et al. 1984; Green et al. 1991). Up to 20 years, the mean number of annual 
attacks has been found to be 6-11, with this ﬁ gure declining to 3-4 per year after 
that (Friberg et al. 1984). Silvestein et al. (1989) reported 57% of MD patients to 
have complete control of their vertigo after 2 years and 71% after 3 or more years 
since onset of the disease. Haye and Quist-Hanssen (1976) found that in 48% 
of the MD patients, the longest period without vertigo attacks was more than 5 
years and in 19% 10 years or more. The impact of vertigo on the ability to work 
has been estimated to be moderate, and the annual working days lost because of 
MD to lie between 0 and 4 (Friberg et al. 1984).
 Drop attacks
Drop attacks (DA) in MD were initially reported by Tumarkin (1936), and thus, 
they are also known as Tumarkin otolithic catastrophes. DA are abrupt attacks 
of falling without loss of consciousness. They occur most often in patients with 
severe and long-lasting MD, but they can also initiate the disease (Black et al. 
1982; Baloh et al. 1990). DA usually last only from a few seconds to no more than 
a minute and are accompanied by cochlear symptoms, including hearing loss, tin-
nitus, and aural pressure (Tumarkin 1936). The patients characteristically feel as 
though they had been pushed and sometimes report a sudden tilting of their sur-
roundings simultaneously with the fall. DA are supposed to result from mechan-
ical deformation of otolithic organs, causing a burst of neural impulses, which 
activates vestibulospinal reﬂ exes (Baloh et al. 1990; Ishiyama et al. 2001). 
The incidence of DA is not known, but they have been reported to occur in 
6–7% of MD patients (Black et al. 1982; Baloh et al. 1990). Ballester et al. (2002) 
found that in MD patients aged over 65 years the incidence of DA depended on 
the type of disease: the incidence was 11% for longstanding MD but 26% when 
the diagnosis had been set after the age of 65. Moreover they reported that 8% 
of elderly MD patients had initially been misdiagnosed mainly because of DA as 
having had a stroke or brainstem ischemia. 
DA resolve spontaneously in the majority of MD patients, and for the 
remainder vestibular nerve section or destruction of the labyrinth - either surgi-
cally or chemically can eliminate the attacks (Janzen and Russell 1988; Ödkvist 
and Bergenius 1988). Ishiyama et al. (2003) reported DA that were related to 
non-MD otologic cause and found the incidence of migraine to be high in this 
group of patients with normal hearing.
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 2. 
Aims of 
the Study
 1.  To study the population-based prevalence of MD.
 2.  To characterize progression and level of hearing loss and tinnitus 
  by duration of MD and to determine their relation to vertigo.
 3.  To evaluate the progression of vertigo by duration of MD with special 
  reference to patients with a long history of persisting symptoms.
 4.  To assess the prevalence of DA in MD patients and to determine whether 
  an association exists between DA and other symptoms of MD.
 5.  To evaluate postural stability and otoneurologic ﬁ ndings by 
  duration of MD. 
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 3. 
Materials and 
Methods
The study protocol was approved by the Ethics Committee of the Helsinki Uni-
versity Central Hospital.
 3.1 Subjects
In Study I, a questionnaire was sent to 5000 randomly selected persons aged 12 
years or more living in the Helsinki University Hospital area. These people were 
randomly selected from the population register data. Forty-seven percent of the 
recipients were men and 53% women. Their mean age was 44 years (range 12-
99 years). The response rate after one postal reminder was 63% (n=3138). After 
exclusions the ﬁ nal study group consisted of 3116 people. Forty-three percent 
of the them were men and 56% women. Their mean age was 45 (range 12-99) 
years.
 A sample of 243 consecutive patients with MD was examined in the Studies 
II–IV. The group consisted of 69 men and 174 women, and their mean age at 
onset of symptoms was 44 (range 17–79) years. Their mean age at the time of 
testing was 50 (range 20-80) years.
A subgroup of 180 patients underwent posturography testing in Study V. 
After excluding one male patient, 179 patients were analyzed for postural sta-
bility. Their mean age at the time of testing was 51 (range 22–80) years for men 
and 49 (range 20-78) years for women. 
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 3.2 Methods
In audiological evaluation, pure-tone audiometry at frequencies of 0,125 kHz 
to 8 kHz was performed by trained audiology assistants using Madsen OB-822 
diagnostic audiometer and TDH-39 headphones. The audiometers were cali-
brated according to ISO standards. The four-tone average of hearing thresholds 
at frequencies of 0.5, 1, 2, and 3 kHz (AAO-HNS 1995) was used to quantify the 
hearing loss.
In Study I, the recipients of questionnaires were asked whether they had 
experienced vertigo together with a moving sensation, hearing loss or tinnitus. 
For exclusion purposes, we also enquired about general illnesses, ear infections, 
former head and ear traumas, noise exposure, medication, and use of tobacco 
and alcohol. Patients with vertigo attacks were asked about their frequency, 
intensity, and duration. They were also asked about provoking factors for ver-
tigo, their age at onset of vertigo symptoms, and whether nausea was present 
during the attacks. Finally, they were asked to estimate the time elapsed since 
their last vertigo attack. To assess the validity of the population-based study, we 
randomly selected a 100-subject sample among the people reporting vertigo. The 
sample was clinically examined in our vestibular unit. The clinical examination 
included complete otorhinolaryngologic and neurologic examinations supple-
mented by audiologic and otoneurologic tests. The following tests were used: 1) 
posturography; quiet stance, eyes open and closed (Starck et al. 1991, 1992), 2) 
ENG; caloric excitability at 44°C and 37°C, asymmetry (>25% considered being 
abnormal), spontaneous nystagmus, saccadic eye movements; peak velocity 
(degree per second), accuracy (degree), and reaction time (milliseconds) (Juhola 
1986), and pursuit eye movements; gain (as percentage) and latency (millisec-
onds) (Juhola 1988). MRI or ABR were done when needed. 
In Studies II-V, the patients completed a questionnaire concerning vertigo, 
hearing loss, tinnitus, earlier diseases, head and ear traumas, and use of tobacco 
and alcohol. This information was supplemented by clinical examination data 
and the results of audiologic, otoneurologic, and imaging studies. The otoneuro-
logic tests consisted of ENG and posturography. 
 3.3 Statistical Analysis 
Data were analyzed with SPSS statistical programs 8.0 and 10.0. Frequencies, 
means, ranges, and standard deviations were calculated for most of the vari-
ables in Studies I–V. In Study V, when data were skewed, medians and ranges 
were expressed. Spearman correlation coefﬁ cients were calculated to determine 
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whether associations existed between different symptoms in Studies I–V. The 
correlation was considered signiﬁ cant at the 0.01 level. The distributions of 
symptoms and ﬁ ndings in patient subgroups were determined by error bar of 
means using 95% conﬁ dence intervals. The group means were compared with 
one-way analysis of variance, signiﬁ cantly (p=0.05) different means were deter-
mined with Tukey’s test in Studies III and V and Duncan’s test in Study IV. In 
Studies III and V, the relationship between variables and duration of MD was 
studied by cross-tabulation and the χ2 test. In Study IV, factor analysis was per-
formed to establish the relationship among variables, and logistic regression 
analysis to group the patients likely to have DA.
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 4. 
Results
 4.1 Prevalence of Menière’s Disease 
 in General Population of Southern Finland (I)
The prevalence of MD was assessed in a general population aged 12 years or 
more. A group of 5000 people aged 12 years or more and living in the Helsinki 
University Hospital area was randomly selected from the population register 
data. This group was sent a questionnaire on symptoms of vertigo, tinnitus, and 
hearing loss. The ﬁ nal study group consisted of 3116 persons. A subgroup of 100 
individuals reporting vertigo was randomly selected among the respondents for 
further clinical evaluation to assess the validity of the population-based study. 
Of the group of 3116 responders 7% (n=216) reported the triad of vertigo, 
hearing loss and tinnitus, but 61% (n=128) of these had not been examined for 
their vertigo symptoms. Subjects with more intense, more frequent, and longer 
lasting vertigo attacks with concomitant nausea were more likely to have vis-
ited a doctor for their symptoms. Cochlear symptoms preceded vertigo in 61% 
of subjects. After excluding subjects who might have another reason for their 
symptoms, 28 possible, 31 probable, and 16 deﬁ nite MD patients remained and 
are presented in Table 4. The group of 16 deﬁ nite MD patients consisted of 13 
women and 3 men. Nine of them had previously been given a MD diagnosis that 
could be conﬁ rmed by medical records. Their mean duration of disease was 19 
(range 2–41) years and their mean age at the onset of symptoms was 44 (range 
19-77) years. 
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Based on the 16 deﬁ nite MD patients found here, the population-based prev-
alence of MD is 513 per 100 000 individuals aged 12 years or more. If we are 
extremely conservative and include only the 10 patients for whom MD diagnosis 
could be conﬁ rmed (9 by medical records and one by clinical examination), 
the rate would be 321 per 100 000 inhabitants. The highest prevalence (1709/
100 000) was seen in the age group 61–70 years. After excluding the deﬁ nite 
MD patients and subjects who might have another reason for their symptoms, 
the prevalence rates for probable and possible MD were 995/100 000 and 899/
100 000 respectively. 
 4.2 Hearing Loss and Tinnitus in Menière’s Disease (II)
A group of 243 deﬁ nite MD patients was evaluated to characterize the progres-
sion and level of hearing loss and tinnitus by duration of MD and to determine 
their relation to vertigo. 
For analysis of progression of MD symptoms by duration of disease, the patients 
were divided into 6 groups based on the time elapsed since the onset of MD. The 
duration groups were 1) <1 week (n=6), 2) 1-4 weeks (n=14), 3) 1–4 months (n=32), 
4) 5–12 months (n=37), 5) 1- 4 years (n=56), and 6) >4 years (n=98).
Hearing loss alone initiated symptoms in 13% of patients. Hearing loss com-
bined with tinnitus was seen in 15% and combined with vertigo in 4% of patients 
as the initial symptom. In 5% tinnitus alone and in 4% tinnitus combined with 
vertigo were the initial symptoms. In 38% of patients, the disease started with 
the full triad. 
Longer duration of the disease was associated with more profound hearing 
loss. Progression of hearing loss was most rapid at the 500 Hz frequency. Fluc-
tuation of hearing was reported by 44% of patients and deterioration of hearing 
Table 4. 
Number of MD patients in the ﬁ nal group of 3116 persons and their mean age at 
the time of attending the study.
    Mean age and
MD Total Women Men range (years)
Deﬁ nitive 16 13 3 61 (39-79)
Probable 31 15 16 51 (20-79)
Possible 28 21 7 54 (23-83)
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during vertigo attacks by 55%. Increased intensity of vertigo attack was linked to 
the deterioration in hearing during the attack. Fluctuation of hearing was signiﬁ -
cantly more common during the ﬁ rst year of symptoms. Patients with more pro-
found hearing loss performed worse on posturography, both with eyes open and 
closed. Level of hearing loss did not correlate with frequency, duration, or inten-
sity of vertigo attacks.
Bilateral tinnitus was more common than bilateral MD in our material, and it 
was experienced as more disturbing and intense than unilateral tinnitus. Thirty-
eight percent of patients scored intensity of their tinnitus as mild, 32% as mod-
erate, and 30% as severe. The intensity of tinnitus increased with duration of dis-
ease as well as with decrease of hearing (Figure 1).
Figure 1. 
Means of PTA of hearing thresholds at 0.5, 1, 2, and 3 kHz 
by intensity of tinnitus with 95% conﬁ dence intervals.
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Intense tinnitus was linked speciﬁ cally to hearing loss at 500 Hz (p<0.05). Tin-
nitus was unaffected by the frequency or duration of vertigo attacks. However, 
patients with intense tinnitus more often had vertigo provoked by head posi-
tioning, physical activity, or pressure changes than those with less intense tin-
nitus. Unsteadiness, moving difﬁ culties outside vertigo attacks, and DA were 
more common among the patients reporting intense tinnitus. Intense tinnitus 
was common in MD and, along with deteriorated hearing, it increased in the 
later stages of the disease. 
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 4.3  Progression of Symptoms of Dizziness 
 in Menière’s Disease (III)
The progression of symptoms of dizziness was studied by duration of MD with 
special attention being paid to patients with long disease duration. 
Patients were allocated into the following 7 duration groups: 1) <4 weeks (n=20), 
2) 1–4 months (n=32), 3) 5–12 months (n=37), 4) 1–4 years (n=56), 5) 5–10 years 
(n=49), 6) 11–20 years (n=32), and 7) >20 years (n=17). 
No differences were found in frequency, intensity, or duration of vertigo 
attacks between the duration groups. However, the number of patients reporting 
continuous vertigo began to grow after a disease duration of 10 years, reaching 
21% among patients who had had MD for 20 years. Vertigo attacks most com-
monly lasted between 5 minutes and 4 hours. The duration of vertigo attacks 
increased as the disease progressed. More than half of patients scored the inten-
sity of their vertigo attacks as moderate or severe, i.e. attacks either forced them 
stop their activity or lie down. The proportion having severe or very severe attacks 
increased with disease progression. The increase in intensity of nausea by dis-
ease duration is presented in Figure 2.
Surgically treated patients reported longer, more intense, and more frequent 
vertigo attacks than those who had not been operated on. Ninety percent of the 
Figure 2. 
Increase in intensity of nausea felt by the patients 
during vertigo attacks by MD duration.
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surgically treated patients considered their attacks to be severe or very severe. 
 The prevalence of bilateral disease increased with disease duration, being 
highest among those with symptoms for more than 20 years. No statistical dif-
ferences were present in intensity, frequency, or duration of vertigo attacks 
between patients with bilateral and those with unilateral MD or between the gen-
ders. A subgroup of patients with MD had severe symptoms of dizziness even 
after a 20-year disease history. 
 4.4 Short-lasting Drop Attacks in Menière’s Disease (IV)
This study assessed the prevalence of DA in MD and determined whether asso-
ciations exists between DA and other symptoms of MD. 
For analysis of progression of MD symptoms by duration of disease, the 
patients were divided into 6 groups based on the time elapsed since the onset 
of MD. The duration groups were 1) <1 week (n=6), 2) 1–4 weeks (n=14), 3) 1–
4 months (n=32), 4) 5–12 months (n=37), 5) 1–4 years (n=56), and 6) >4 years 
(n=98).
DA were deﬁ ned as rapid attacks of falling or slips without loss of conscious-
ness. The occurrence together with description of attacks and severity of attacks 
were speciﬁ cally enquired about in the questionnaire. To assess the daily distur-
bance caused by DA, the frequency of attacks was divided into the following 3 
classes: 1) mild disturbance with DA appearing seldom or being mild, 2) mod-
erate disturbance with more frequent DA or DA being moderate, and 3) severe 
disturbance with DA occurring several times a day or being severe.
DA were experienced by 72% (n=173) of MD patients. They were mild in 42% 
(n=72), moderate in 49% (n=85), and severe in 9% (n=16) of patients. No differ-
ence was seen in mean duration of MD, age at onset of symptoms, intensity of 
vertigo, or gender between the DA and non-DA groups. In patients with DA, tin-
nitus was more severe and vertigo attacks were more likely provoked by visual 
factors (e.g. rapid movement in surrounding), pressure changes (e.g .ﬂ ying or 
sneezing), head positioning, or physical strain than in patients without DA. DA 
patients also had more moving difﬁ culties outside vertigo attacks than did non-
DA patients. Patients with DA had more anxiety than those without DA (Figure 
3.) They also had more cranial nerve symptoms, including facial sensitivity dis-
turbances, visual blurring, and dysarthria, than non-DA patients. In the otoneu-
rologic tests, no differences were present between the DA and non-DA groups. 
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4.5 Postural Instability in Menière’s Disease (V)
The Study V evaluated the progression of postural stability in MD patients by 
both hearing stage and disease duration.
Patients were divided into following 7 duration groups: 1) <4 weeks (n=15), 
2) 1–4 months (n=28), 3) 5–12 months (n=28), 4) 1–4 years (n=50), 5) 5–10 years 
(n=30), 6) 11–20 years (n=19), and 7) >20 years (n=20). 
 We used static computerized platform posturography to measure postural 
stability. The measurements were done with eyes open and closed, the latter to 
exhibit visual control. The SV were expressed as the length of the path of the 
center point of force divided by the time (mm/sec). To examine the relation-
ship between patients’ hearing level and their SV values, we further divided the 
patients by their PTA of hearing thresholds (0,5, 1, 2, and 3 kHz) into 4 hearing 
stages deﬁ ned by AAO-HNS as I <26 dB, II 26-40 dB, III 41-70 dB, and IV >70 
dB. The mean age of the patients at the time of testing was 51 (range 22-80) 
years. 
No signiﬁ cant difference was observed in mean SV between the seven dura-
Figure 3. 
Relationship between anxiety and drop attacks with 95% conﬁ dence 
intervals. Anxiety rated as 0) none, 1) mild, 2) moderate, or 3) severe.
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tion groups. Neither was there any difference in caloric asymmetry (≤25%) 
between the different duration groups. Caloric response was normal 65% of the 
patients, and in this group 60% had a normal SV with eyes open and 57% with 
eyes closed.
The SV values measured with eyes open and eyes closed correlated well with 
each other (r=0.76). The SV values in the entire group were within the normal 
range in 58% (n=103) of the patients, with eyes open and in 55% (n=99) with 
eyes closed. No statistical difference was present in mean SV between the dif-
ferent duration groups of MD. Patients affected with bilateral MD swayed 
slightly more with eyes open as well as closed than unilaterally affected patients, 
but the difference was not signiﬁ cant. 
In the group with more severe disease (severe or very severe attacks lasting 
more than 4 hours, at least 1-4 times a month), SV was within the normal range 
in 63% of cases, both with eyes open and closed. The patients belonging to 
hearing stage III (PTA 41-70 dB) swayed signiﬁ cantly more than patients in stage 
I (PTA <25 dB). Since mean age and age range were alike in these two groups, 
the result cannot be explained by age. The large variability in SV between the 
subjects having same PTA is presented in Figure 4.
 
Figure 4. 
Scatter plot of SV with eyes open by PTA of hearing thresholds 
at 0.5, 1, 2, and 3 kHz. 
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 5. 
Discussion
 5.1 General Discussion
A large population-based data was collected to assess the prevalence of MD in a 
general population (I). The progression of cochlear symptoms, including tinnitus 
and hearing loss, their relationship with vertigo, and characteristics of tinnitus in 
MD were evaluated (II). The symptoms of dizziness in MD were studied by dura-
tion of disease, with special reference to patients with a long history of the dis-
ease (III). The occurrence of DA was examined and the relationship between DA 
and other symptoms of MD was evaluated (IV). Postural instability was assessed 
by both hearing stage and duration of MD (V). 
The mean age of 44 years at the onset of MD symptoms in Studies II-IV was 
the same as the mean age at onset in the 16 deﬁ nite MD patients of the popula-
tion study (I). The clear female predominance seen in Studies II-V (70% women 
vs. 30% men) was also seen in 16 deﬁ nite MD patients (80% vs. 20%) (I).
The proportion of patients with bilateral MD increased with duration of the 
disease (III). While patients with bilateral disease did not have more severe ver-
tigo symptoms than patients with unilateral disease, bilateral tinnitus was expe-
rienced as more disturbing than unilateral tinnitus (II). Forty-two percent of sub-
jects with severe tinnitus reported having DA quite often or several times a day. 
Black et al. (1982) reported DA to be more common in severe and long-lasting 
MD, a ﬁ nding conﬁ rmed here.
 5.2 Prevalence of Menière’s Disease
The population-based prevalence of MD was calculated to be 513 per 100 000 
individuals. This ﬁ nding is much higher than earlier estimations of prevalence 
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based on hospital registers (Stahle et al.1978; Watanabe et al.1995; Kotimäki et 
al.1999). Wladislavosky-Waserman et al (1984) reported a fairly high ﬁ gure of 
218/100 000 in Rochester, Minnesota, for the period 1951-1980. Their material 
included 436 MD or Menière’s syndrome patients. However, only 180 of their 
patients met the diagnostic guidelines of that time (1972). With respect to the 
revised 1995 criteria, the prevalence would have been much lower (Wladislav-
osky-Waserman et al. 1984). Our prevalence rate for deﬁ nite MD using the most 
recent criteria (1995) is twice the ﬁ gure of Wladislavosky-Waserman et al. (1984) 
and more than ten times that of Kotimäki et al. (1999). 
Hospital registers have weaknesses. Data collected in routine clinical work 
vary in quality and are limited in consistency, accuracy, availability, and complete-
ness of medical records (da Costa et al. 2002). We encountered this dilemma 
in the case of a MD patient diagnosed during the examination of the vertigo 
sample. Despite her several visits to the outpatient polyclinic of the Department 
of Otorhinolaryngology in the 1970s, no mention of her vertigo symptoms was 
found in her medical records. Her auditory symptoms appeared to be the main 
problem at the time because she received a diagnosis of cochlear degeneration 
and was given a hearing aid but no treatment for her vertigo attacks, which con-
tinued after her last visit to the clinic.
Arenberg et al. (1980) claimed that mostly moderate and severe cases of MD 
are found in the studies based on hospital material; we agree with this. When 
evaluating the group with the triad of symptoms, we noticed that the longer, the 
more intense and the more frequent the vertigo attacks, the more probable the 
previous examinations were because of vertigo symptoms.
Tokomasu et al. (1996) reported cochlear symptoms to precede the onset of 
vertigo attacks in 61% of patients. In Study I, cochlear symptoms preceded ver-
tigo ones in 61% of subjects with the triad of symptoms and in 54% of patients 
with deﬁ nite MD. When the cochlear signs appear ﬁ rst there is the risk that they 
become attributed to another cause and when the vestibular symptoms become 
apparent the triad of symptoms may go unrecognized particularly, due to epi-
sodic nature of the vestibular symptoms (Arenberg et al. 1980). It is harder to 
link the new vestibular symptoms to persisting hearing loss.
We found only 3 men in the group of 16 deﬁ nite MD patients, which might 
suggest that the actual prevalence rate is even higher than we reported. MD has, 
after all, been considered to affect both genders equally (Tokomasu et al. 1995; 
Katsarkas 1996). Kotimäki et al. (1999) in their prevalence study did not give 
separate prevalence ﬁ gures for men and women. We speculate that men are less 
eager than women to participate in questionnaire-based studies, although 43% 
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of our responders were men. The possibility also exists that women are more 
affected by MD than men in Finland. 
Wladislavosky et al. (1984) reported a peak incidence in the age group 45-59 
years, but estimated that the rate would increase with age with a small decrease 
occurring in the oldest age group of 75 years and over. We noticed a peak in 
prevalence of 1709/100 000 in the age group 61–70 years and a small decline 
in the age group over 70 years. The possibility of MD should be kept in mind 
regarding these age groups which are also affected by presbyacusis and whose 
vertigo might easily be diagnosed as being of central origin.
Patients reporting a history of brain ischemia were excluded from our prev-
alence calculations and this might have affected (lowered) the prevalence rates. 
Some of these patients who had been diagnosed as having brain ischemia might 
actually be MD patients with DA or MD patients with later occurring ischemic 
disease. However, without the possibility for a clinical examination, we had to 
exclude these patients. Patients reporting headache symptoms, by contrast, 
were included in the prevalence calculations due to the high prevalence rate of 
migraine in MD patients. Some of these patients might actually be afﬂ icted with 
migraineous vertigo, but because they met the criteria of MD, they were consid-
ered MD patients with migraines. 
The small number of men in our prevalence calculation and the strict criteria 
used for exclusion may underestimate the actual prevalence rate. On the other 
hand, children under the age of 12 years were not included in the study, and 
if the assumption that those more affected by the symptoms in question were 
more eager to answer the questionnaire is held to be valid, these would lower 
the calculated prevalence rate. These two aspects may to some degree compen-
sate each another.
 5.3 Hearing Loss and Tinnitus in Menière’s Disease
Our MD patients were collected from the vestibular unit of Helsinki University 
Hospital. They ﬁ lled in a questionnaire concerning their symptoms. Of the 243 
patients, cochlear symptoms started the disease in 33%, supporting the view that 
MD patients whose disease starts with vestibular symptoms are more likely to 
receive a correct diagnosis. In our population-based study ( I ), 54% of the deﬁ -
nite MD patients had started their disease with cochlear symptoms. Tokomasu et 
al. (1996) reported 61% of MD patients in Japan start their disease with cochlear 
symptoms.
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 Katsarkas (1996) found that hearing degreases at a more or less ﬁ xed rate 
but some variation is present in the decline of vestibular function. In our study, 
no correlation was seen between the degree of hearing loss and caloric asym-
metry in ENG.
Bilateral tinnitus was more often, than unilateral tinnitus experienced as 
severe. One-third of patients scored their tinnitus as severe. More intense tin-
nitus has been reported in the late stages of MD (Kolbe et al. 2000). This ﬁ nding 
of increased intensity can be explained partly by increased hearing loss and bilat-
eral tinnitus with disease duration. 
 5.4 Vertigo in Menière’s Disease
Vertigo attacks in MD were reported to resolve in 30% or disappear in 54% of 
patients in a 9- year follow-up (Green et al.1991). A decline in the frequency of 
attacks has been estimated to occur after two decades have elapsed since onset 
of the disease (Friberg et al.1984). Nausea-associated vertigo attacks are rarer 
after the ﬁ rst year of MD has passed (Oosterveld 1979). In our study, when eval-
uating a group of MD patients, whose disease duration varied from recent onset 
to 41 years, we did not ﬁ nd frequency, intensity or duration of vertigo attacks 
to decrease with disease duration. Seventy-ﬁ ve percent of patients who had had 
MD for more than 20 years considered their vertigo attacks to be severe, and 
36% still had attacks 1-4 times a week. Nausea associated with vertigo attacks 
was most common among those with a long disease history. Our hospital is a 
tertiary referral clinic which attends to patients with the most persistent and 
severe symptoms, and 20% of our sample had had symptoms for more than 10 
years. This tertiary nature of our clinic presumably also had an inﬂ uence on the 
high number of severe symptoms found in the group of patients who had had 
MD more than 20 years. Many people apparently are freed of their MD symp-
toms over time since there were considerably less patients in the late-disease 
duration groups than the earlier duration groups would have suggested. Surgi-
cally treated patients reported longer, more intense, and more frequent attacks 
than those who had not been operated on. This can be explained by them having 
more severe symptoms overall, with this being the reason for their operation. It 
also supports what has earlier been reported: endolympatic sac surgery does not 
alter the long-term natural course of MD or modiﬁ es it slightly (Silverstein et al. 
1989, Filipo and Barbara 1997).
Consistent with earlier studies, we found bilateral illness to increase with 
duration of MD (Stahle 1976; Friberg et al. 1984 and Tokomasu et al. 1995). 
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Compared with 47% reported by Friberg et al. (1984), we found 43% of patients 
to have bilateral disease after 20 years had elapsed since onset of the disease. 
The overall proportion of patients with bilateral disease was 16%.
 5.5 Drop Attacks in Menière’s Disease
DA, i.e. sudden falls without loss of consciousness, have been speculated to 
account for a considerable proportion of potentially dangerous falls in older 
people (Ishiyama et al. 2001). Ballester et al. (2002) reported that 8% of elderly 
MD people aged over 65 years had initially being misdiagnosed as having had a 
stroke or brainstem ischemia because of DA. 
We found DA in 72% of MD patients, in stark contrast to the much lower ﬁ g-
ures 6-7% reported earlier ( Black et al. 1982; Baloh et al. 1990). The high prev-
alence can be explained by the fact that all of the patients reporting DA probably 
would not had reported DA that caused only mild or moderate disability had it 
not been speciﬁ cally inquired about. Only 9% of our patients had severe DA - 
a ﬁ gure similar to the prevalence rates of the authors above. Black et al. (1982) 
reported DA to be more common in severe and long-lasting MD, a ﬁ nding con-
sistent with ours. Our hospital being a tertiary referral clinic may increase the 
prevalence of DA found in MD patients.
In 65% of MD patients with DA, vertigo attacks were provoked by rapid move-
ments in the environment and in 71% by head movements. These patients no 
longer rely on vestibular information to maintain their balance, instead relying 
on visual and proprioseptive information. In their study on conservative man-
agement of DA patients, Janzen and Russell (1988) concluded that this patient 
group can beneﬁ t from visually secure surroundings. 
 5.6 Postural Instability in Menière’s Disease
MD patients are thought to be more dependent on visual input than people 
with normal vestibular function (Black 1982), and thus, measuring SV with the 
patient’s eyes closed is considered to be a tool to remove this visual control. We 
found, however, that eyes-open and eyes-closed SV values correlated well with 
each other (r=0.76). 
Declined hearing was linked to worse performance on the platform. Our 
study did not, however, provide evidence that posturography would be helpful 
in evaluating progression of MD. There was a large subject to subject variability 
in posturography performing. Evans and Krebs (1999) stated that posturography 
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and ENG ﬁ ndings do not correlate with each other and at its best posturography 
only modestly enhances the diagnosis of peripheral vestibular hypofunction. 
Most useful posturography could be in evaluating the effect of rehabilitation and 
thus receiving objective information on the functional status of balance impaired 
patients. Paparella (1991) found that up to 50% of MD patients have normal 
reactions in caloric tests even when affected by severe vestibular symptoms. This 
is in agreement with our results. 
 5.7 Future Aspects
The link between MD and migraine is interesting and worthy of further investi-
gations. The medication used in migraine patients has already shown to alleviate 
migraine-related dizziness. If its efﬁ cacy extends to MD patients, this would help 
a group that has thus sufferred from an intractable disease. The development 
of imaging studies enables detailed information to be collected on the inner 
ear and the brain that could previously be only obtained postmortem. These 
advanced imaging studies will improve differentiation between MD and symp-
toms of vertigo, tinnitus, and hearing loss of central origin, and thus, should be 
used more. 
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 6. 
Conclusions
Based on the ﬁ ndings of Studies I–V the following conclusions were drawn:
1.  The population-based prevalence of deﬁ nite MD is 513 per 100 000 individ-
uals aged 12 years or more. A peak in prevalence (1709/100 000) was seen 
in the age group 61–70 years (I).
2.  Hearing loss and tinnitus intensity progress in MD patients with disease 
duration. More intense tinnitus was seen in bilateral cases who had longer 
disease duration (II).
3.  A subgroup of patients with MD continues to have severe symptoms of diz-
ziness 20 years after onset of the disease. The prevalence of bilateral disease 
increases with duration of illness, but patients with bilateral MD did not 
have more severe vertigo symptoms than those with unilateral disease (III). 
4.  DA are common in MD patients and are especially seen in the advanced 
stage of the disease. DA patients are more dependent on visual and proprio-
ceptive information than MD patients without DA (IV).
5.  Postural stability did not deteriorate with the duration of MD. Patients with 
more advanced hearing loss performed worse on the platform, and this 
ﬁ nding was not age-dependent (V).
6.  The enhancement of imaging studies is important in differentiating MD 
symptoms from the central causes of symptoms. 
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 7. 
Summary
Objectives: The prevalence of Menière’s disease (MD) in a general population 
and the presence of three major symptoms of MD, vertigo, hearing loss, and tin-
nitus, by duration of disease were evaluated. 
Subjects and methods: To study the prevalence of MD in a general population, a 
questionnaire was sent to 5000 randomly selected people aged 12 years or more 
living in the Helsinki University Hospital area. The individuals receiving the 
questionnaire were asked whether they had experienced vertigo associated with 
a moving sensation, hearing loss, or tinnitus. For exclusion purposes, we also 
enquired about general illnesses, ear infections, former head and ear traumas, 
noise exposure, medication and use of tobacco and alcohol. The response rate 
after one postal reminder was 63%. To assess the validity of the population-based 
study, we randomly selected a 100 subject-sample among the people reporting 
vertigo. The sample was clinically examined in our vestibular unit. A total of 243 
consecutive MD patients were evaluated to clarify the clinical picture of MD.
Results: The population-based prevalence of deﬁ nite MD was 513 per 100 000 
inhabitants aged 12 years or more, with a peak prevalence of 1709 per 100 000 
inhabitants seen in the age group 61–70 years. If we are extremely conservative 
and include only the 10 patients for whom MD diagnosis could be conﬁ rmed, 
the rate would still be 321 per 100 000 inhabitants. The true prevalence can, 
however, be considered to be 513 per 100 000 inhabitants. The cochlear symp-
toms of hearing loss and tinnitus severity increased with disease duration. In 
54% of deﬁ nite MD patients, the disease started with cochlear symptoms. A sub-
group of patients still had severe symptoms of dizziness 20 years after disease 
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onset. The prevalence of bilateral MD was most common late in the disease, 
but patients with bilateral disease did not have more severe vertigo symptoms 
than patients with unilateral disease. Short-lasting drop attacks were experienced 
by 72% of the MD patients, and they were typically seen in the advanced stage 
of the disease. Postural stability did not deteriorate with duration of MD, but 
patients with advanced hearing loss were found more unstable. 
Conclusions: The prevalence of deﬁ nite MD here was much higher than pre-
vious reports based on hospital records have suggested. A peak in prevalence 
was seen in the age group 61–70 years. The possibility of MD should be consid-
ered in this age group also affected by presbyacusis and whose vertigo might be 
diagnosed as being of central origin. When cochlear symptoms start the disease, 
there is a risk that they may be misattributed to another cause or presumed to 
be due to aging, and triad of symptoms may go undiagnosed. Imaging studies 
should be used to differentiate between MD patients and patients with vertigo 
because of vascular disorder. Although MD symptoms may resolve with time, a 
subgroup of patients continues to have severe symptoms 20 years after onset of 
the disease. 
60 summary
03_Havia_M   60 23.8.2004, 08:23:16
03_Havia_M   61 23.8.2004, 08:23:17
03_Havia_M   62 23.8.2004, 08:23:17
 8. 
Acknowledgments
This study was conducted at the Department of Otorhinolaryngology of Helsinki 
University Central Hospital. I am grateful to Professor Pekka Karma, Professor 
Jukka Ylikoski, and Docent Hans Ramsay for providing me with the facilities to 
carry out this work. 
My deepest gratitude is due to my the supervisors Professor Ilmari Pyykkö 
and Dr Erna Kentala. Professor Pyykkö’s visionary ideas and creativeness laid the 
foundation for this project. Dr Kentala’s skilful way of solving the many prob-
lems I encountered was invaluable, her patience and quidance making the com-
pletion of this work possible. 
I am also grateful to the referees of this thesis: Docent Reijo Johansson and 
Dosent Tapani Rahko for their thoroughness and constructive criticism, which 
greatly improved the ﬁ nal version of the manuscript. I thank them both for 
sharing their vast experience in neurotology with me, and for their encouraging 
attitude towards my study. The days I spent in Turku and Tampere are most 
memorable. 
I thank Professor Hilkka Riihimäki, Head of the Department of Epidemi-
ology and Statistics at the Finnish Institute of Occupational Health, for her valu-
able comments regarding the prevalence study. I appreciate the information on 
posturography measurements that Heikki Aalto provided for my study on pos-
tural instability. Hanna Oksanen, is thanked for invaluable assistance with the 
statistical analyse of Studies III and V. Carol Ann Pelli is kindly thanked for the 
revising the English language of this thesis.
The audiological assistants and other personnel in the auditory unit of the 
Department of Otorhinolaryngology are thanked for performing the audiological 
and otoneurological measurements. Dr Jukka Karikoski is especially acknowl-
acknowledgments 63
03_Havia_M   63 23.8.2004, 08:23:17
edged for his valuable comments. I thank Mirja Haapanen, Teo Hämäläinen, 
and Mika Nikkola for their friendliness and for always being ready to give a 
helping hand in practical matters. Marlene Wanhatalo, is thanked for locating 
articles, even those I thought were impossible to get ahold of. 
My sincere thanks is due to my colleagues and friends Karin Blomgren, Elina 
Toskala-Hannikainen, and Paula Virkkula for sharing the knowledge they have 
acquired in their own research with me. Karin, in particular, is acknowledged 
for the advice she so generously offered concerning computer problems with the 
reference program. All fellow residents and specialists at the Department of Oto-
rhinolaryngology are thanked for the years spent together at the clinic. 
I am deeply grateful to Pia Linnamaa, Hannele Koillinen, and Reija Hietala – 
my colleagues and good friends for over two decades. The long discussions espe-
cially during hard times and the joyful moments spent together have been indis-
pensable to me. 
This study was ﬁ nancially supported by the Biomedicum Helsinki Founda-
tion, the Finnish Ear Research Foundation, and Helsinki University Central 
Hospital Special Funds.
   
Helsinki, August 2004
Mari Havia 
64 acknowledgments
03_Havia_M   64 23.8.2004, 08:23:18
03_Havia_M   65 23.8.2004, 08:23:18
03_Havia_M   66 23.8.2004, 08:23:18
references 67
Aalto H, Pyykkö I, Starck J. Computerized posturography, a development of the measuring 
system. Acta Otolaryngol Suppl 449: 71–5, 1988. 
Adams RD. Occlusion of the anterior inferior cerebellar artery. Arch Neurol Psychiatry 49: 
765–770, 1943. 
Akagi H, Yuen K, Maeda Y, Fukushima K, Kariya S, Orita Y, Kataoka Y, Ogawa T, Nishizaki 
K. Meniere’s disease in childhood. Int J Pediatr Otorhinolaryngol 61 (3): 259–64, 2001. 
American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS). Committee on 
Hearing and Equilibrium. Committee on Hearing and Equilibrium guidelines for the 
diagnosis and evaluation of therapy in Meniere’s disease. Otolaryngol Head Neck Surg 
113 (3): 181–5, 1995. 
Alford BR. Committee on Hearing and Equilibrium. Report of Subcommittee on Equilibrium 
and its Measurement. Meniere’s disease: criteria for diagnosis and evaluation of therapy 
for reporting. Trans Am Acad Ophthalmol Otolaryngol 76 (6): 1462–4, 1972. 
Antoni-Candela F. The histopathology of Meniere’s disease. Acta Otolaryngol Suppl (Stockh) 
340: 1–42, 1976. 
Arenberg IK, Balkany TJ, Goldman G, Pillsbury RC, 3rd. The incidence and prevalence of 
Meniere’s disease – a statistical analysis of limits. Otolaryngol Clin North Am 13 (4): 597–
601, 1980. 
Asai M, Watanabe Y, Ohashi N, Mizukoshi K. Evaluation of vestibular function by dynamic 
posturography and other equilibrium examinations. Acta Otolaryngol Suppl 504: 120–4, 
1993. 
Ballester M, Liard P, Vibert D, Hausler R. Meniere’s disease in the elderly. Otol Neurotol 23 
(1): 73–8, 2002. 
Baloh RW. Advances in neuro-otology. Curr Opin Neurol 11 (1): 1–3, 1998. 
Baloh RW. Approach to the evaluation of the dizzy patient. Otolaryngol Head Neck Surg 112: 
3–7, 1995. 
Baloh RW. Neurotology of migraine. Headache 37 (10): 615–21, 1997. 
Baloh RW. Prosper Meniere and his disease. Arch Neurol 58 (7): 1151–6, 2001. 
 9. 
References
03_Havia_M   67 23.8.2004, 08:23:18
68 references
Baloh RW. Superior semicircular canal dehiscence syndrome. Neurology 62: 684–685, 
2004. 
Baloh RW, Honrubia V, Jacobson K. Benign positional vertigo: clinical and oculographic 
features in 240 cases. Neurology 37 (3): 371–8, 1987. 
Baloh RW, Honrubia V, Sills A. Eye-tracking and optokinetic nystagmus. Results of 
quantitative testing in patients with well-deﬁ ned nervous system lesions. Ann Otol Rhinol 
Laryngol 86 (1 Pt 1): 108–14, 1977. 
Baloh RW, Jacobson K, Winder T. Drop attacks with Meniere’s syndrome. Ann Neurol 28 (3): 
384–7, 1990. 
Baloh RW, Jacobson KM, Enrietto JA, Corona S, Honrubia V. Balance disorders in older 
persons: quantiﬁ cation with posturography. Otolaryngol Head Neck Surg 119 (1): 89–92, 
1998. 
Beasley NJ, Jones NS. Meniere’s disease: evolution of a deﬁ nition. J Laryngol Otol 110 (12): 
1107–13, 1996. 
Bhansali SA, Honrubia V. Current status of electronystagmography testing. Otolaryngol 
Head Neck Surg 120 (3): 419–26, 1999. 
Bikhazi P, Jackson C, Ruckenstein MJ. Efﬁ cacy of antimigrainous therapy in the treatment of 
migraine-associated dizziness. Am J Otol 18 (3): 350–4, 1997. 
Billings PB, Keithley EM, Harris JP. Evidence linking the 68 kilodalton antigen identiﬁ ed in 
progressive sensorineural hearing loss patient sera with heat shock protein 70. Ann Otol 
Rhinol Laryngol 104 (3): 181–8, 1995. 
Black FO. Vestibular function assessment in patients with Meniere’s disease: the 
vestibulospinal system. Laryngoscope 92 (12): 1419–36, 1982. 
Black FO, Effron MZ, Burns DS. Diagnosis and management of drop attacks of vestibular 
origin: Tumarkin’s otolithic crisis. Otolaryngol Head Neck Surg 90 (2): 256–62, 1982. 
Brenner M, Hoistad DL, Hain TC. Prevalence of thyroid dysfunction in patients with 
Meniere’s disease. Arch Otolaryngol Head Neck Surg 130 (2): 226–8, 2004. 
Buongiorno G, Ricca G. Supratentorial arachnoid cyst mimicking a Meniere’s disease attack. 
J Laryngol Otol 117 (9): 728–30, 2003.  
Calenoff E, Zhao JC, Derlacki EL, Harrison WH, Selmeczi K, Dutra JC, Olson IR, Hanson 
DG. Patients with Meniere’s disease possess IgE reacting with herpes family viruses. 
Arch Otolaryngol Head Neck Surg 121 (8): 861–4, 1995. 
Caplan LR. Intracranial branch atheromatous disease: a neglected, understudied, and 
underused concept. Neurology 39 (9): 1246–50, 1989. 
Casselman JW. Diagnostic imaging in clinical neuro-otology. Curr Opin Neurol 15: 23–30, 
2002. 
Casselman JW, Offeciers EF, De Foer B, Govaerts P, Kuhweide R, Somers T. CT and MR 
imaging of congential abnormalities of the inner ear and internal auditory canal. Eur J 
Radiol 40 (2): 94–104, 2001. 
Cawthorne T, Hewlett AB. Meniere’s disease. Proc R Soc Med 47 (8): 663–70, 1954. 
Celestino D, Ralli G. Incidence of Meniere’s disease in Italy. Am J Otol 12 (2): 135–8, 1991. 
03_Havia_M   68 23.8.2004, 08:23:19
references 69
Charcot JM. Conferences cliniques de Salpetriere: Vertiges ab aure laesa (maladie de 
Menière). Gaz des Hospiteaux Civils et Militaires 47: 73–74, 1874. 
Choung YH, Park K, Moon SK, Kim CH, Ryu SJ. Various causes and clinical characteristics 
in vertigo in children with normal eardrums. Int J Pediatr Otorhinolaryngol 67 (8): 889–
94, 2003. 
Clemis JD. Allergy of the inner ear. Ann Allergy 25: 370–376, 1967. 
Cohen H, Ewell LR, Jenkins HA. Disability in Meniere‘s disease. Arch Otolaryngol Head 
Neck Surg 121 (1): 29–33, 1995. 
Colebatch JG. Vestibular evoked potentials. Curr Opin Neurol 14: 21–26, 2001. 
Conlon BJ, Gibson WP. Meniere’s Disease: The incidence of hydrops in the contralateral 
asymptomatic ear. Laryngoscope 109 (11): 1800–1802, 1999. 
Conlon BJ, Gibson WP. Electrocochleography in the diagnosis of Meniere’s disease. Acta 
Otolaryngol 120 (4): 480–3, 2000. 
Dahlen AI, Fex S, Henriksson NG, Pyykkö I, Wennmo C. Dyspraxia of speech and of eye 
motility. Acta Otolaryngol 89 (1–2): 144–51, 1980. 
Davidson HC, Harnsberger HR, Lemmerling MM, Mancuso AA, White DK, Tong KA, 
Dahlen RT, Shelton C. MR evaluation of vestibulocochlear anomalies associated with 
large endolymphatic duct and sac. AJNR Am J Neuroradiol 20 (8): 1435–41, 1999. 
da Costa SS, de Sousa LC, de Toledo Pisa MR. Meniere’s disease: overview, epidemiology, 
and natural history. Otolaryngol Clin N Am 35 (3): 455–495, 2002. 
de Sousa LC, Piza MR, da Costa SS. Diagnosis of Meniere’s disease: routine and extended 
tests. Otolaryngol Clin North Am 35 (3): 547–64, 2002. 
Derebery MJ. Allergic management of Meniere’s disease: an outcome study. Otolaryngol 
Head Neck Surg 122 (2): 174–82, 2000. 
Derebery MJ, Rao VS, Siglock TJ, Linthicum FH, Nelson RA. Meniere’s disease: an immune 
complex-mediated illness? Laryngoscope 101 (3): 225–9, 1991. 
Devaiah AK, Ator GA. Clinical indicators useful in predicting response to the medical 
management of Meniere’s disease. Laryngoscope 110 (11): 1861–5, 2000. 
Devaiah AK, Dawson KL, Ferraro JA, Ator GA. Utility of area curve ratio 
electrocochleography in early Meniere disease. Arch Otolaryngol Head Neck Surg 129 (5): 
547–51, 2003. 
Di Fabio RP. Meta-analysis of the sensitivity and speciﬁ city of platform posturography. Arch 
Otolaryngol Head Neck Surg 122 (2): 150–6, 1996. 
Dornhoffer JL, Colvin GB. Benign paroxysmal positional vertigo and canalith repositioning: 
clinical correlations. Am J Otol 21 (2): 230–3, 2000. 
Duke WW. Meniere’s syndrome caused by allergy. JAMA 81: 2179, 1923. 
Eaton DA, Roland PS, Mabry RL, Shoup AG. Electrocochleography and intranasal allergen 
challenge as investigational tools in patients with inhalant allergy and Meniere’s disease. 
Laryngoscope 113 (1): 33–6, 2003. 
Enander A, Stahle J. Hearing in Meniere’s disease. A study of pure-tone audiograms in 334 
patients. Acta Otolaryngol 64 (5): 543–56, 1967. 
03_Havia_M   69 23.8.2004, 08:23:20
70 references
Endicott JN, Stucker FJ. Allergy in Meniere’s disease related ﬂ uctuating hearing loss 
preliminary ﬁ ndings in a double-blind crossover clinical study. Laryngoscope 87 (10 Pt 1): 
1650–7, 1977. 
Epley JM. The canalith repositioning procedure: for treatment of benign paroxysmal 
positional vertigo. Otolaryngol Head Neck Surg 107 (3): 399–404, 1992. 
Evans MK, Krebs DE. Posturography does not test vestibulospinal function. Otolaryngol 
Head Neck Surg 120 (2): 164–73, 1999. 
Feenstra L. The management of tinnitus with or without Meniere’s disease. Acta Otolaryngol 
Suppl 526: 47–9, 1997. 
Fitzgerald DC. Head trauma: hearing loss and dizziness. J Trauma 40 (3): 488–96, 1996. 
Fransen E, Verstreken M, Verhagen WI, Wuyts FL, Huygen PL, D’Haese P, Robertson NG, 
Morton CC, McGuirt WT, Smith RJ, Declau F, Van de Heyning PH, Van Camp G. High 
prevalence of symptoms of Meniere’s disease in three families with a mutation in the 
COCH gene. Hum Mol Genet 8 (8): 1425–9, 1999. 
Friberg U, Stahle J, Svedberg A. The natural course of Meniere’s disease. Acta Otolaryngol 
Suppl 406: 72–7, 1984. 
Fuse T, Hayashi T, Oota N, Fukase S, Asano S, Kato T, Aoyagi M. Immunological responses 
in acute low-tone sensorineural hearing loss and Meniere’s disease. Acta Otolaryngol 123 
(1): 26–31, 2003. 
Gibson WP, Prasher DK. Electrocochleography and its role in the diagnosis and 
understanding of Meniere’s disease. Otolaryngol Clin North Am 16 (1): 59–68, 1983. 
Gibson WP, Prasher DK, Kilkenny GP. Diagnostic signiﬁ cance of transtympanic 
electrocochleography in Meniere’s disease. Ann Otol Rhinol Laryngol 92 (2 Pt 1): 155–9, 
1983. 
Gomez CR, Cruz-Flores S, Malkoff MD, Sauer CM, Burch CM. Isolated vertigo as a 
manifestation of vertebrobasilar ischemia. Neurology 47 (1): 94–7, 1996. 
Gottschlich S, Billings PB, Keithley EM, Weisman MH, Harris JP. Assessment of serum 
antibodies in patients with rapidly progressive sensorineural hearing loss and Meniere’s 
disease. Laryngoscope 105 (12 Pt 1): 1347–52, 1995. 
Grad A, Baloh RW. Vertigo of vascular origin. Clinical and electronystagmographic features 
in 84 cases. Arch Neurol 46 (3): 281–4, 1989. 
Green JD, Jr., Blum DJ, Harner SG. Longitudinal followup of patients with Meniere’s 
disease. Otolaryngol Head Neck Surg 104 (6): 783–8, 1991. 
Gross EM, Ress BD, Viirre ES, Nelson JR, Harris JP. Intractable benign paroxysmal 
positional vertigo in patients with Meniere’s disease. Laryngoscope 110 (4): 655–9, 2000. 
Haarmeier T, Thier P. Impaired analysis of moving objects due to deﬁ cient smooth pursuit 
eye movements. Brain 122 ( Pt 8): 1495–505, 1999. 
Hallpike CS, Cairns H. Observations on the pathology of Meniere’s syndrome. J Laryngol 
Otol 53: 625–654, 1938. 
Hamid MA, Sismanis A. Curr Opin Otolaryngol Head Neck Surg 9: 319–322, 2001. 
Harrison MS, Naftalin L. Meniere’s Disease: Mechanism and Management. Springﬁ eld IL: 
Charles C Thomas, 1968. 
03_Havia_M   70 23.8.2004, 08:23:21
references 71
Haye R, Quist-Hanssen S. The natural course of Meniere’s disease. Acta Otolaryngol 82 (3–
4): 289–93, 1976. 
Hinojosa R, Kohut RI. Clinical diagnosis of anterior inferior cerebellar artery thrombosis. 
Autopsy and temporal bone histopathologic study. Ann Otol Rhinol Laryngol 99 (4 Pt 1): 
261–72, 1990. 
Hytönen M, Pyykkö I, Aalto H, Starck J. Postural control and age. Acta Otolaryngol 113 (2): 
119–22, 1993. 
Hägnebo C, Melin L, Larsen HC, Lindberg P, Lyttkens L, Scott B. The inﬂ uence of vertigo, 
hearing impairment and tinnitus on the daily life of Meniere patients. Scand Audiol 26 
(2): 69–76, 1997. 
Ishiyama A, Jacobson KM, Baloh RW. Migraine and benign positional vertigo. Ann Otol 
Rhinol Laryngol 109 (4): 377–80, 2000. 
Ishiyama G, Ishiyama A, Baloh RW. Drop Attacks and Vertigo Secondary to a Non-Meniere 
Otologic Cause. Arch Neurol 60: 71–75, 2003. 
Ishiyama G, Ishiyama A, Jacobson K, Baloh RW. Drop attacks in older patients secondary to 
an otologic cause. Neurology 57 (6): 1103–6, 2001. 
Janzen VD, Russell RD. Conservative management of Tumarkin’s otolithic crisis. J 
Otolaryngol 17 (7): 359–61, 1988. 
Johnson GD. Medical management of migraine-related dizziness and vertigo. Laryngoscope 
108 (1 Pt 2): 1–28, 1998. 
Juhola M. A syntactic method for analysis of nystagmus and smooth pursuit eye movement. 
Comput Methods Programs Biomed 26 (1): 53–62, 1988. 
Juhola M. A syntactic method for analysis of saccadic eye movements. Pattern Recognition 
19: 353–359, 1986. 
Kaasinen S, Pyykkö I, Ishizaki H, Aalto H. Effect of intratympanically administered 
gentamicin on hearing and tinnitus in Meniere’s disease. Acta Otolaryngol Suppl 520 Pt 
1: 184–5, 1995. 
Katsarkas A. Hearing loss and vestibular dysfunction in Meniere’s disease. Acta Otolaryngol 
116 (2): 185–8., 1996. 
Kentala E. Characteristics of six otologic diseases involving vertigo. Am J Otol 17 (6): 883–92, 
1996. 
Kentala E, Pyykkö I. Clinical picture of vestibular schwannoma. Auris Nasus Larynx 28 (1): 
15–22, 2001. 
Kentala E, Pyykkö I. Vestibular schwannoma mimicking Meniere’s disease. Acta Otolaryngol 
Suppl 543: 17–9, 2000. 
Kimura H, Aso S, Watanabe Y. Prediction of progression from atypical to deﬁ nite Meniere’s 
disease using electrocochleography and glycerol and furosemide tests. Acta Otolaryngol 
123 (3): 388–95, 2003. 
Kolbe U, Brehmer D, Schaaf H, Hesse G. Tinnitus HG, Morbus Meniere. In: 4th 
International Symposium on Meniere’s disease, Hague, 2000. 
Kotimäki J. Meniere’s disease in Finland. An epidemiological and clinical study on 
occurence, clinical picture and policy, University of Oulu, 2003. 
03_Havia_M   71 23.8.2004, 08:23:22
72 references
Kotimäki J, Sorri M, Muhli A. Prognosis of hearing impairment in Meniere’s disease. Acta 
Otolaryngol Suppl 545: 14–8, 2001. 
Kotimäki J, Sorri M, Aantaa E, Nuutinen J. Prevalence of Meniere’s Disease in Finland. 
Laryngoscope 109: 748–753, 1999. 
Kumar A, Petchenik L. The diagnosis and management of vertigo. Compr Ther 16 (12): 56–
66, 1990. 
Lee CS, Paparella MM, Margolis RH, Le C. Audiological proﬁ les and Meniere’s disease. Ear 
Nose Throat J 74 (8): 527–32, 1995. 
Lee H, Lopez I, Ishiyama A, Baloh RW. Can migraine damage the inner ear? Arch Neurol 57 
(11): 1631–4, 2000. 
Lee H, Sohn SI, Jung DK, Cho YW, Lim JG, Yi SD, Lee SR, Sohn CH, Baloh RW. Sudden 
deafness and anterior inferior cerebellar artery infarction. Stroke 33 (12): 2807–12, 2002. 
Lee H, Whitman GT, Lim JG, Yi SD, Cho YW, Ying S, Baloh RW. Hearing symptoms in 
migrainous infarction. Arch Neurol 60 (1): 113–6, 2003. 
Lempert T, Leopold M, von Brevern M, Neuhauser H. Migraine and benign positional 
vertigo. Ann Otol Rhinol Laryngol 109 (12 Pt 1): 1176, 2000. 
Levine S, Margolis RH, Daly KA. Use of electrocochleography in the diagnosis of Meniere’s 
disease. Laryngoscope 108 (7): 993–1000, 1998. 
Lim JS, Lange ME, Megerian CA. Serum antidiuretic hormone levels in patients with 
unilateral Meniere’s disease. Laryngoscope 113 (8): 1321–6, 2003. 
Lustig LR, Yeagle J, Niparko JK, Minor LB. Cochlear implantation in patients with bilateral 
Meniere’s syndrome. Otol Neurotol 24 (3): 397–403, 2003. 
Magliulo G, Cuiuli G, Gagliardi M, Ciniglio-Appiani G, D’Amico R. Vestibular evoked 
myogenic potentials and glycerol testing. Laryngoscope 114 (2): 338–43, 2004. 
Mancini F, Catalani M, Carru M, Monti B. History of Meniere’s disease and its clinical 
presentation. Otolaryngol Clin North Am 35 (3): 565–80, 2002. 
Mateijsen DJ, Kingma CM, De Jong PE, Wit HP, Albers FW. Aldosterone assessment in 
patients with Meniere’s disease. ORL J Otorhinolaryngol Relat Spec 63 (5): 280–6, 2001a. 
Mateijsen DJ, Van Hengel PW, Van Huffelen WM, Wit HP, Albers FW. Pure-tone and 
speech audiometry in patients with Meniere’s disease. Clin Otolaryngol 26 (5): 379–87, 
2001b. 
Matsushita K, Naritomi H, Kazui S, Watanabe Y, Okazaki H, Kuriyma Y, Sawada T. 
Infarction in the anterior inferior cerebellar artery territory: magnetic resonance imaging 
and auditory brain stem responses. Cerebrovasc Dis 3: 206–212, 1993. 
McCabe BE. Autoimmune Sensorineural Hearing Loss. Ann Otol Rhinol Laryngol 88: 585–
589, 1979. 
Menière P. Pathologie auriculaire: Mémoire sur des lésions de l’oreille interne donnant lieu a 
des symptômes de congestion cérébrale apolectiforme. Gaz Med Paris 16: 597–641, 1861. 
Meurman OH, Grahne B. Hearing in Meniere’s disease. Practica Oto-Rhinol-Laryngologica 
18: 365–376, 1956. 
Meyerhoff WL, Paparella MM, Gudbrandsson FK. Clinical evaluation of Meniere’s disease. 
Laryngoscope 91 (10): 1663–8, 1981. 
03_Havia_M   72 23.8.2004, 08:23:23
references 73
Meyerhoff WL, Paparella MM, Shea D. Meniere’s disease in children. Laryngoscope 88 (9 Pt 
1): 1504–11, 1978. 
Minor LB. Labyrinthine ﬁ stulae: pathobiology and management. Curr Opin Otolaryngol 
Head Neck Surg 11: 340–346, 2003. 
Minor LB, Solomon D, Zinreich JS. Sound-  and/or pressure-induced vertigo due to bone 
dehiscence of the superior semicircular canal. Arch Otolaryngol Head Neck Surg 124: 
249–258, 1998. 
Monsell EM, Furman JM, Herdman SJ, Konrad HR, Shepard NT. Computerized dynamic 
platform posturography. Otolaryngol Head Neck Surg 117 (4): 394–8, 1997. 
Mori N, Asai H, Doi K, Matsunaga T. Diagnostic value of extratympanic electrocochleography 
in Meniere’s disease. Audiology 26 (2): 103–10, 1987. 
Morrison AW. Anticipation in Meniere’s disease. J Laryngol Otol 109 (6): 499–502, 1995. 
Morrison AW, Johnson KJ. Genetics (molecular biology) and Meniere’s disease. Otolaryngol 
Clin North Am 35 (3): 497–516, 2002. 
Nedzelski JM, Barber HO, McIlmoyl L. Diagnoses in a dizziness unit. J Otolaryngol 15 (2): 
101–4, 1986. 
Neuhauser H, Leopold M, von Brevern M, Arnold G, Lempert T. The interrelations of 
migraine, vertigo, and migrainous vertigo. Neurology 56 (4): 436–41, 2001. 
Odabasi O, Hodges AV, Balkany TJ. Electrocochleography: validity and utility. Curr Opin 
Otolaryngol Head Neck Surg 8: 375–379, 2000. 
Okafor BC. Incidence of Meniere’s disease. J Laryngol Otol 98 (8): 775–9, 1984. 
Oliveira CA, Ferrari I, Messias CI. Occurrence of familial Meniere’s syndrome and migraine 
in Brasilia. Ann Otol Rhinol Laryngol 111 (3 Pt 1): 229–36, 2002. 
Olsson JE. Neurotologic ﬁ ndings in basilar migraine. Laryngoscope 101 (1 Pt 2 Suppl 52): 1–
41, 1991. 
O’Neill DE, Gill-Body KM, Krebs DE. Posturography changes do not predict functional 
performance changes. Am J Otol 19 (6): 797–803, 1998. 
Oosterveld WJ. Meniere’s disease, a survey of 408 patients. Acta Otorhinolaryngol Belg 33 
(3): 428–31, 1979. 
Paparella MM. Methods of diagnosis and treatment of Meniere’s disease. Acta Otolaryngol 
Suppl 485: 108–19, 1991. 
Paparella MM, Djalilian HR. Etiology, pathophysiology of symptoms, and pathogenesis of 
Meniere’s disease. Otolaryngol Clin N Am 35 (3): 529–545, 2002 
Paparella MM, Mancini F. Trauma and Meniere’s syndrome. Laryngoscope 93 (8): 1004–12, 
1983. 
Pappas DG, Jr., Pappas DG, Sr., Carmichael L, Hyatt DP, Toohey LM. Extratympanic 
electrocochleography: diagnostic and predictive value. Am J Otol 21 (1): 81–7, 2000. 
Parnes LS, McClure JA. Free-ﬂ oating endolymph particles: a new operative ﬁ nding during 
posterior semicircular canal occlusion. Laryngoscope 102 (9): 988–92, 1992. 
Pearson BW, Brackmann DE. Committee on Hearing and Equilibrium guidelines for 
reporting treatment results in Meniere’s disease. Otolaryngol Head Neck Surg 93 (5): 
579–81, 1985. 
03_Havia_M   73 23.8.2004, 08:23:24
74 references
Perez N, Martin E, Zubieta JL, Romero MD, Garcia-Tapia R. Benign paroxysmal positional 
vertigo in patients with Meniere’s disease treated with intratympanic gentamycin. 
Laryngoscope 112 (6): 1104–9, 2002. 
Proctor LR. Results of serial vestibular testing in unilateral Meniere’s disease. Am J Otol 21 
(4): 552–8, 2000. 
Pulec JL. Meniere’s disease: results of a two and one-half-year study of etiology, natural 
history and results of treatment. Laryngoscope 82 (9): 1703–15, 1972. 
Radtke A, Lempert T, Gresty MA, Brookes GB, Bronstein AM, Neuhauser H. Migraine and 
Meniere’s disease: is there a link? Neurology 59 (11): 1700–4, 2002. 
Rauch SD, San Martin JE, Moscicki RA, Bloch KJ. Serum antibodies against heat shock 
protein 70 in Meniere’s disease. Am J Otol 16 (5): 648–52, 1995. 
Rauch SD, Zurakowski D, Bloch DB, Bloch KJ. Anti-heat shock protein 70 antibodies in 
Meniere‘s disease. Laryngoscope 110 (9): 1516–21, 2000. 
Riente L, Bongiorni F, Nacci A, Migliorini P, Segnini G, Delle Sedie A, Ursino F, Tommasi 
S, Fattori B. Antibodies to inner ear antigens in Meniere’s disease. Clin Exp Immunol 135 
(1): 159–63, 2004. 
Rosenberg SI. Natural history of acoustic neuromas. Laryngoscope 110 (4): 497–508, 2000. 
Ryan AF, Keithley EM, Harris JP. Autoimmune inner ear disorders. Curr Opin Neurol 14 (1): 
35–40, 2001. 
Segal S, Eviatar E, Berenholz L, Kessler A, Shlamkovitch N. Dynamics of sensorineural 
hearing loss after head trauma. Otol Neurotol 23 (3): 312–5, 2002. 
Segal S, Eviatar E, Berenholz L, Kessler A, Shlamkovitch N. Is there a relation between 
acoustic trauma or noise-induced hearing loss and a subsequent appearance of Meniere’s 
Disease? An epidemiologic study of 17245 cases and a review of the literature. Otol 
Neurotol 24 (3): 387–91, 2003. 
Selmani Z, Pyykkö I, Ishizaki H, Ashammakhi N. Use of electrocochleography for assessing 
endolymphatic hydrops in patients with Lyme disease and Meniere’s disease. Acta 
Otolaryngol 122 (2): 173–8, 2002. 
Shea JJ, Jr., Ge X, Orchik DJ. Traumatic endolymphatic hydrops. Am J Otol 16 (2): 235–40, 
1995. 
Shojaku H, Watanabe Y, Mizukoshi K, Kitahara M, Yazawa Y, Watanabe I, Ohkubo J. 
Epidemiological Study of Severe Cases of Meniere’s Disease in Japan. Acta Otolaryngol 
Stockh Suppl 520: 415–418, 1995. 
Silver RD, Djalilian HR, Levine SC, Rimell FL. High-resolution magnetic resonance imaging 
of human cochlea. Laryngoscope 112 (10): 1737–41, 2002. 
Silverstein H, Smouha E, Jones R. Natural history vs. surgery for Meniere’s disease. 
Otolaryngol Head Neck Surg 100 (1): 6–16, 1989. 
Somers TH, Casselman J, de Ceulaer G. Prognostic value of magnetic resonance imaging 
ﬁ ndings in hearing preservation surgery for vestibular scwannoma. Otol Neurotol 22: 87–
94, 2001. 
Stahle J. Advanced Meniere’s disease. A study of 356 severely disabled patients. Acta 
Otolaryngol 81 (1–2): 113–9, 1976. 
03_Havia_M   74 23.8.2004, 08:23:25
references 75
Stahle J, Friberg U, Svedberg A. Long-term progression of Meniere’s disease. Acta 
Otolaryngol Suppl 485: 78–83, 1991. 
Stahle J, Stahle C, Arenberg K. Incidence of Meniere’s Disease. Arch Otolaryngol 104: 99–
102, 1978. 
Starck J, Pekkarinen J, Pyykkö I, Aalto H, Toppila E. Transmission of vibration from support 
surface to human body in the evaluation of postural stability. J Low Freq Noise Vibr 1991 
10 (1): 1–7, 1991. 
Starck J, Pyykkö I, Aalto H, Pekkarinen J. Measurements of postural stability: development of 
a force platform and some excitation systems. Med Prog Technol 18 (4): 209–15, 1992. 
Stouffer JL, Tyler RS. Characterization of tinnitus by tinnitus patients. J Speech Hear Disord 
55 (3): 439–53, 1990. 
Takeda T, Kakigi A, Saito H. Antidiuretic hormone (ADH) and endolymphatic hydrops. Acta 
Otolaryngol Suppl 519: 219–22, 1995. 
Terekhov Y. Stabilometry as a diagnostic tool in clinical medicine. Can Med Assoc J 115 (7): 
631–3, 1976. 
Tokumasu K, Fujino A, Naganuma H, Hoshino I, Arai M. Initial symptoms and retrospective 
evaluation of prognosis in Meniere’s disease. Acta Otolaryngol Suppl 524: 43–9, 1996. 
Tokumasu K, Fujino A, Yoshio S, Hoshino I. Prognosis of Meniere’s disease by conservative 
treatment: retrospective study on the time course of the disease. Acta Otolaryngol Suppl 
519: 216–8, 1995. 
Troost BT. Dizziness and vertigo in vertebrobasilar disease. Part II. Central causes and 
vertebrobasilar disease. Stroke 11 (4): 413–5, 1980. 
Tumarkin A. The otolithic catastrophe: a new syndrome. Br med J 1: 175–7, 1936. 
Usami S, Takahashi K, Yuge I, Ohtsuka A, Namba A, Abe S, Fransen E, Patthy L, Otting G, 
Van Camp G. Mutations in the COCH gene are a frequent cause of autosomal dominant 
progressive cochleo-vestibular dysfunction, but not of Meniere’s disease. Eur J Hum 
Genet 11 (10): 744–8, 2003. 
Vernon J, Johnson R, Schleuning A. The characteristics and natural history of tinnitus in 
Meniere’s disease. Otolaryngol Clin North Am 13 (4): 611–9, 1980. 
Vrabec JT. Herpes simplex virus and Meniere’s disease. Laryngoscope 113 (9): 1431–8, 2003. 
Watanabe Y, Mizukoshi K, Shojaku H, Watanabe I, Hinoki M, Kitahara M. Epidemiological 
and clinical characteristics of Meniere’s disease in Japan. Acta Otolaryngol 519 (206–10), 
1995. 
Weber PC, Adkins WY. The differntial diagnosis of Meniere’s disease. Otolaryngol Clin 
North Am 30 (6): 977–96, 1997. 
Welsh LW, Welsh JJ, Jaffe SC, Healy MP. Syndromal vertigo identiﬁ ed by magnetic 
resonance imaging and angiography. Laryngoscope 106 (9 Pt 1): 1144–51, 1996. 
Welsh LW, Welsh JJ, Lewin B. Vertigo: analysis by magnetic resonance imaging and 
angiography. Ann Otol Rhinol Laryngol 109 (3): 239–48, 2000. 
Wennmo C, Hindfelt B, Pyykkö I. Eye movements in cerebellar and combined 
cerebellobrainstem diseases. Ann Otol Rhinol Laryngol 92 (2 Pt 1): 165–71, 1983. 
Wiet RJ. Patterns of ear disease in the southwestern American Indian. Arch Otolaryngol 105 
(7): 381–5, 1979. 
03_Havia_M   75 23.8.2004, 08:23:26
76 references
Wilmot TJ. Meniere’s disorder. Clin Otolaryngol 4 (2): 131–43, 1979. 
Wladislavosky-Waserman P, Facer GW, Mokri B, Kurland LT. Meniere’s disease: a 30–year 
epidemiologic and clinical study in Rochester, Mn, 1951–1980. Laryngoscope 94 (8): 
1098–102, 1984. 
Yamakawa K. Uber die Patologische Veranderung bei einem Meniere-Kranken. Oto-Rhino-
Laryngol, Organ der Japan. O R L Gesellschaft 44: 192–193, 1938. 
Ylikoski J, Palva T, Sanna M. Dizziness after head trauma: clinical and morphologic ﬁ ndings. 
Am J Otol 3 (4): 343–52, 1982. 
Young YH, Huang TW, Cheng PW. Assessing the stage of Meniere’s disease using vestibular 
evoked myogenic potentials. Arch Otolaryngol Head Neck Surg 129 (8): 815–8, 2003. 
Zou J, Pyykkö I, Bretlau P, Klason T, Bjelke B. In vivo visualization of endolymphatic 
hydrops in guinea pigs: magnetic resonance imaging evaluation at 4.7 tesla. Ann Otol 
Rhinol Laryngol 112 (12): 1059–65, 2003. 
03_Havia_M   76 23.8.2004, 08:23:27
03_Havia_M   77 23.8.2004, 08:23:27
03_Havia_M   78 23.8.2004, 08:23:27
appendix 79
Population Questionnaire
Please answer the following questions and circle the 
most appropriate alternative.
Surname:                                            
First name:
Social security number:
Sex:     
Woman / Man              
Age:                   
Height:           
Weight:
Place of residence (e.g. town, countryside):
Smoking:  
Yes / No      
Does your skin get easily burned by the sun?: 
Always / Often / Sometimes / never
Occupation (also the previous one):   
Education:    
a) elementary school
b) trade school
c) college
d) secondary school graduate
e) university
 10.
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Have you been exposed to noise in your work?    
Yes
No
Has the use of hearing protection been recommend or is the noise level 
in your work over 85 dB?                                                                         
Yes
No
How long have you been exposed to noise in your work?
Noise level at work?
Have you had a     
1) head trauma                           
Yes
No
2) sudden acoustic trauma
Yes
No
Have you had recurrent (more than 3) middle ear infections?
Yes
No
Do you consider your hearing to be normal for a person of your age?  
Yes
No
If your hearing is impaired, please answer the following questions:
Is there a speciﬁ c reason for your hearing loss?
      
Is your hearing impaired:  
In the Right                  
Left                  
Both ears?
Does your hearing ﬂ uctuate?
Yes
No
Do you suffer from your impaired hearing?  
Not at all
A little
Quite a lot
Very much
Has your hearing level been measured?    
Yes
No
Do you know your hearing level?
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Do you suffer from ringing or humming in your ears?
Not at all
A little
Quite a lot
Very much
If ringing or humming occurs, is it in your
Right
Left
Both ears?
Do you suffer from headaches?
Not at all
A little
Quite a lot
Very much
Do you ever faint?
Never
Seldom
Sometimes
Very often
Are you on medication on a regular basis?          
What medication?
Yes
No
Do you have any of the following diseases?
Hypertonia
Diabetes
Coronary artery disease
Brain circulation disorder
Thyroid disorder
Another disease:
Is your cholesterol level above normal?               
Yes
No
What is your cholesterol level?
Have you experienced sudden falls or staggered without loss of consciousness?
Yes
No
Have you experienced vertigo together with a moving sensation?
Yes
No
If you answered “yes” to the previous question, please answer the following 
questions. If you answered “no”, we thank you for your participation and for 
returning the questionnaire.
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How long have you experienced vertigo?
How old were you when your vertigo symptoms began?
How much do you suffer from your vertigo?
Not at all
A little
Quite a lot
Very much
How often does vertigo occur?
a) only one time
b) less than once a year
c) 1-2 times a year
d) 3-12 times a year
e) 1-4 times a month
f)  2-7 times a week
g) several times  a day
h) constantly
How long does the sensation of vertigo last?
a) less than 15 seconds
b) 15 seconds-5 minutes
c) more than 5 minutes-4 hours
d) more than 4 hours-24 hours
e) several days
Does nausea occur concomitantly with vertigo?
a) never
b) seldom
c) often
d) always
How intense is your attack?
a) mild (can continue working)
b) moderate (have to stop working)
c) severe (have to rest)
d) very severe (have trouble even in rest)
Have you noticed anything that might provoke vertigo? If yes, what?
When did you have your last episode of vertigo?
Have you been examined by a doctor for vertigo?   
Yes
No
Does vertigo  affect your work ability?
Yes
No
If you have more than one of the above symptoms (vertigo, hearing loss, tinnitus), which was 
the ﬁ rst to appear?
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